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Abstract
Implementation of an Advance Care Planning Discussion for Patients with Chronic
Kidney Disease
Chelsea Hinders
2017

Clinical practice guidelines (CPGs) support the need for providers to engage patients in a
discussion of goals and priorities regarding end-of-life care through the use of advance
care planning (ACP) (Agency for Healthcare Research and Quality [AHRQ], 2014).
However, current data demonstrated a lack of implementation specific to patients with
chronic kidney disease (CKD). A five question standardized tool developed from current
guidelines served as the discussion guide for this intervention. Despite the great need for
this project, patients who were eligible for the intervention were not willing to be active
participants in an ACP discussion. The clinical significance, most notably the increased
awareness of the nephrology Nurse Practitioner (NP) and other clinic providers,
demonstrated ACP can be successful. Further research is needed to transform the topic
of ACP in both research and practice.
Keywords: advance care planning, advance directive, chronic kidney disease
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Chapter 1
Introduction
Introduction
The kidneys are a paired organ system that filter, reabsorb, and excrete solutes,
water, and harmful toxins from the body. Fluids, electrolytes, and acid-base balance are
closely regulated by this organ system as well as the production of vitamin D and
erythropoietin (Chisholm-Burns et al., 2013). When part or all of these functions are lost
for a time period of greater than three months, chronic kidney disease (CKD) develops.
Those who are plagued with CKD experience a progressive loss of kidney function that
can occur over months to years. This decline is often irreversible and may result in endstage renal disease (ESRD) at which point dialysis or another form of renal replacement
therapy may be required (Chisholm-Burns et al., 2013).
A large number of individuals may be unaware they are living with CKD making
it challenging to successfully treat this condition. In addition, patients with CKD are
older, usually have multiple comorbid conditions, and face death earlier than the average
individual (Wasylynuk & Davison, 2015). This raises the need for advance care planning
(ACP) in this patient population. Defined more thoroughly, ACP is a process involving
reflection, discussion, and structured communication between a patient, family member,
caregiver, close friend, and/or a health care provider that helps to clarify an individual’s
health status, prognosis, values, goals, and treatment preferences for end-of-life care
(Davison, 2012). However, ACP is not part of the routine care of patients with CKD,
despite the chronic and debilitating nature of the condition (Wasylynuk & Davison,
2015).
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Significance of the Problem
CKD exists along a continuum of stages one to five based on glomerular filtration
rate (GFR). Kidney damage is present at stage two and ESRD exists at stage five
(Chisholm-Burns et al., 2013). Today, CKD plagues nearly 26 million Americans and
millions of others may be at risk for this diagnosis (National Kidney Foundation, 2016).
Five years ago, one in 10 American adults was living with some form of CKD (U.S.
Department of Health and Human Services, National Institutes of Health [NIH], 2012).
In addition, the incidence of CKD was greatest among those 65 years of age and older,
with this rate more than doubling between 2000 and 2008 (NIH, 2012). Alarmingly,
these numbers continued to grow by about 10% per year (Harrison & Watson, 2011).
Mortality is much higher in those with ESRD than in the general population. In
2009, the number of deaths from ESRD totaled over 90,000, as compared to just over
10,000 in 1980 (NIH, 2012). Patients who were referred to a nephrologist or who started
dialysis later in the disease process had significantly poorer survival rates and were at risk
for an earlier death as compared to their healthier counterparts. The later stages of CKD,
such as stages four and five, are often accompanied by a less than optimal health state,
less residual kidney function, and longer periods of acute hospitalizations (Wasylynuk &
Davison, 2015).
Failure to establish an individual’s own goals of care, such as what occurs during
ACP, often resulted in unnecessary admissions to the hospital, invasive procedures, and
more aggressive care than individually desired for patients with CKD (Davison, 2012).
CKD may seem like an easy disease to control and manage, but an individual’s CKD
progression is largely unpredictable and no definitive prognosis can be effectively made
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(Wasylynuk & Davison, 2015). These facts together stress the need for an early
discussion about a patient’s wants, goals, and desires should they near the end-of-life
quicker than imagined.
Those without an advance directive (AD) lack specific goals of care for their endof-life. In a time of a health crisis, those nearest to the patient, such as family members,
close friends, or even health care providers, must make decisions regarding a patient’s
treatment. This can result in unnecessary stress for these persons and uncertainty in their
decision making since a discussion about what should and should not be done in this
situation has never been discussed with the patient. These treatments can go against what
the patients would want for themselves without an exact document stating their wishes.
The end result may hover between two ends of the spectrum, prolonging life
unnecessarily or allowing patients to die despite their desire to continue with aggressive
treatment. However, a successfully implemented ACP discussion allows patients to
enjoy their last few days giving them time to reflect on their prior life experiences with
self-worth. Having a developed AD prior to experiencing a health crisis or the end-oflife often ensures these crucial matters have been voiced with those closest to them.
The concept of ACP focuses on the early identification of individual needs, wants,
and desires should a patient become incapable of making his or her own decisions. It
involves naming a surrogate decision maker, discussing individual goals of care with
family members, close friends, or health care providers, and making critical decisions as
to what is desired at or near the end-of-life (Wasylynuk & Davison, 2015). The
development of an advance care plan is often a continuous process, revisited by the
patient, family member, and health care provider at many successive visits once the
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initial topic had been brought forth (Davison, 2012). Widespread use of ACP enhances
communication between patients and providers, improves quality of life for patients and
family members, reduces unnecessary and unwanted hospitalizations, and decreases
health care costs (Rietjens et al., 2016). Nicholas, Langa, Iwashyna, and Weir’s (2011)
study showed Medicare beneficiaries with treatment-limiting ADs spent up to $380,200
on end-of-life care as compared to those without ADs, whose costs were $522,754. Lifesustaining treatment differences between the two groups were statistically significant for
those with an AD using less than half of the resources required by those without an AD
(Nicholas et al., 2011). While the necessity of ACP has been stressed in multiple
settings, this work flow continues to be underutilized today, despite a great patient desire
to partake in these conversations (Goff et al., 2015).
Those who reported previously using ACP described increased control over
medical situations, relief of burdens on loved ones, and strengthened relationships with
family members (Holley, 2012). However, specifically for patients with CKD, nearly
half of all patients living with ESRD have some form of cognitive impairment and are
unable to participate in decision making at the end-of-life (Feely et al., 2016). Moderate
to severe cognitive impairment was common in over 70% of dialysis patients, despite
having no history of former changes in mental status (Davison, 2012). This change is
thought to occur due to blood vessel disease and resulting hypoperfusion, or decrease in
blood flow, to the brain cells. Brain imaging of these patients commonly showed areas of
damaged tissue and an increased risk of stroke due to this decrease in blood flow
(Tamura & Yaffe, 2011). In addition, depression was common and often unrecognized
among those with CKD, both before and during dialysis therapy (Davison, 2012). Death,
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hospitalization, and disability rates were higher among those with this condition in
conjunction with CKD (Tamura & Yaffe, 2011). The above issues contribute negatively
to ACP and hinder a patient’s ability to actively participate in end-of-life decision making
once the disease has progressed. These psychiatric conditions make it more difficult to
formulate an advance care plan or AD document with this patient population.
ACP is a fluid process, not a single act, that should first occur with the patient and
his or her family members. One of the most beneficial times for ACP to occur in patients
with CKD is when dialysis or other conservative options are first presented to the patient
and/or family members. After this topic is first presented to the patient, it is then brought
up at successive office visits and is revisited on a regular basis to ensure the patient’s care
plan remains consistent with one’s wants, goals, and desires for their end-of-life care
(Davison, 2012). ACP focuses on an individual’s broad goals of care and helps serve as a
facilitator of discussion among patients, families, and health care providers. In this
population, specific goals to be addressed through ACP include the decision to start or
stop dialysis or to pursue other forms of renal replacement therapy. However, a lack of
knowledge of the ACP process among this patient population is a major barrier to its
current use.
ADs are also an important component of ACP. In 1991, the Patient Self
Determination Act stressed the necessity of ensuring patients enact ADs to guarantee
their goals for end-of-life care are honored at a very critical point in their lives. However,
this law did little to increase the use and completion of ADs, as only 36% of the United
States population had documented their wishes for end-of-life care in 2011 (Pecanac,
Repenshek, Tennenbaum, & Hammes, 2014). Encouraging patients to have these crucial
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conversations and to engage in ACP is not only essential to good end-of-life care but
provides patients with this chronic condition some control over one part of their lives.
The high prevalence of CKD, its unpredictable course, and the relatively small
number of individuals who had completed ADs or participated in the unique process of
ACP stressed the impetus to explore this concern further through this Doctor of Nursing
Practice (DNP) Project. Given the compounding factors listed above, matching
individual goals of care with the care received as the disease progresses is critical for
patients with CKD (Goff et al., 2015). In communication with an Advance Practice
Registered Nurse (APRN), ACP specific to patients with CKD is not a routine and
consistent process implemented in an urban Midwestern nephrology clinic (K. Jerke,
personal communication, May 19, 2016). As health care providers, the implementation
and consistent use of ACP can result in more informed and prepared patients and family
members. The purpose of this DNP Project was to help patients identify their personal
goals of care in the CKD disease process, decide for themselves what it is they want for
their last few months, and promote a more dignified dying process.
Population of Interest
The population of interest included adult patients who were in CKD stages four
and five based on GFR without an existing AD document. GFR is defined as the amount
of blood filtered across the capillary of the kidney, or the glomerulus, per unit time, based
on serum creatinine level, age, sex, and race (Harrison & Watson, 2011). A normal GFR
is more than 90 mL/min/1.73 m2. Age-related declines in kidney function are common;
however, one does not normally progress to stages four and five without persistent kidney

ADVANCE CARE PLANNING

7

damage. Stage four CKD is defined as a GFR between 15-29 mL/min/1.73 m2 and stage
five is a GFR less than 15 mL/min/1.73 m2 (Chisholm-Burns et al., 2013).
Other risk factors associated with CKD include low kidney mass, low birth
weight, being of a racial or ethnic minority, having a family history of kidney disease,
and having a low income or low education level (Chisholm-Burns et al., 2013). Diabetes
is the most common cause of CKD while hypertension is a close second, especially when
these conditions are uncontrolled. Together, these two illnesses account for roughly twothirds of all cases of impaired kidney function (National Kidney Foundation, 2016).
Other diseases, such as autoimmune diseases, polycystic kidney disease, urinary tract
infections, and elevated cholesterol levels can all contribute to an increased incidence of
CKD. Often, once sustained damage has occurred to an individual’s kidneys, it is
impossible to regain prior function (Chisholm-Burns et al., 2013).
Patients with CKD stages four and five were chosen for the project sample due to
the chronicity of this health condition. Once a patient reaches these stages, kidney
damage is irreversible and ESRD is most likely to result. A thorough discussion of
dialysis and other forms of renal replacement therapy takes place between the patient and
health care provider once a patient reaches these advanced stages of kidney disease. An
individual’s prognosis and the limited treatment options can be addressed with ACP.
Informed health care consumers can make more realistic choices and will have the
potential to experience a quality of life they are satisfied with, even with a diagnosis of an
incurable health care condition.
A large group of patients are likely to benefit from the implementation of ACP.
This includes patients with CKD who have decided to manage their health conservatively
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without dialysis or other forms of renal replacement therapy, those whom a trained health
care provider knows have a poor prognosis or are near death, and those who are
considering withdrawing from dialysis therapy. Patients who have difficulty determining
simple goals of care, those who have experienced great functional decline within the last
year, and those who have experienced an acute change in health, such as a debilitating
stroke or heart attack, may also be appropriate for a structured use of ACP (Davison,
2012). However, it is essential to understand that any patient with CKD can benefit from
the process of ACP. As it has been developed today, ACP can and should be used with
any patient at any time.
Clinical Question
The clinical question for this DNP Project was asked in PICOT format. P stands
for patient population, I stands for intervention, C stands for comparison intervention, O
stands for outcome, and T stands for time frame (Melnyk & Fineout-Overholt, 2011).
(P) In adult patients with CKD stages four and five in an urban Midwestern
nephrology clinic, does (I) implementation of an ACP discussion (C) compared to usual
care (O) increase patient knowledge of ACP and increase completion of ADs (T) over a
three month time period?
For the last six years, the DNP Project coordinator’s clinical practice has focused
on the care of patients with CKD. Oftentimes, it was stressful health situations,
unexpected illnesses, or tragic situations that triggered ACP to occur in patients of this
type. These patients failed to acknowledge the extent of their situation and refused to
prepare for their final days. Family members routinely felt unprepared to make these
difficult decisions and were often uncertain about what it was the patient desired.
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Desperate measures, such as ventilator support, use of feeding tubes, and long surgical
procedures were initiated and death became a painful process for all involved, including
the health care providers and staff caring for these patients. A gap existed in a patient’s
knowledge of preparing for the end-of-life and actually partaking in these processes.
This DNP Project hoped to enable ACP to become an integral part of the care of patients
with CKD and as such, allowed each patient to achieve his or her goals and desires at the
end-of-life.
Purpose of the Project
The purpose of this DNP Project was to implement a standardized process of ACP
specific to patients with CKD stages four and five in an urban Midwestern nephrology
clinic. The usual care in this setting was while rooming a patient, the nursing staff asked
the patient if he or she had an AD document completed. If the patient did not, he or she
was then asked if he or she would like information on completing one. Information on
forming an advance care plan was sometimes provided but it was not specific to the care
of patients with CKD. No further steps were identified in regards to ACP or the
completion of ADs. The usual care was replaced with an ACP process specific to
patients with CKD. Implementation of this intervention aimed to introduce patients to
the process of ACP and enabled eligible patients to see the necessity of an ACP
discussion. It was a goal of this project to increase patient knowledge of the process of
ACP after the completion of the intervention. In addition, patients would be enabled to
complete an AD document and it was the desire that they would be more easily able to
state their wishes for their end-of-life care with their family members and health care
providers after participating in this consistent ACP intervention.
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This project aimed to allow ACP to become a routine, dynamic practice in the
care of all patients with CKD at this outpatient clinic. Over time, it is the goal that
patients will experience a greater quality of life at the end-of-life, patient wishes will be
more easily honored at the end-of-life with the use of and increase in the completion of
AD documents, and family members can be assured they are following their loved ones
wishes as he or she approaches the end-of-life. In addition, health care costs may
decrease as patients who partake in ACP often choose less life-sustaining treatment
measures and experience fewer unnecessary hospitalizations at the end-of-life (Rietjens et
al., 2016).
Definitions
Adult – a person who is fully grown or of age
Advance care planning (ACP) – a crucial process of thought and
communication in which a cognitively sound person makes future health and/or personal
care decisions in the event that they become incapable of making these decisions
(Wasylynuk & Davison, 2015). Advance care planning is a continuous process that
occurs over many office visits and should be revisited with the patient on a regular basis
(Davison, 2012).
Advance directive (AD) – a document prepared by a competent adult that
provides views, wishes, and directions on the steps to be taken on matters pertaining to
health and medical treatment at a time when an individual is unable to make those
decisions (Pandya, 2015). These tangible documents are sometimes referred to as written
instructional directives. ADs are a distinct part of the process of ACP (White et al.,
2014).
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Chronic kidney disease (CKD), also known as chronic renal insufficiency or
progressive kidney disease – presence of kidney damage that is present for a time period
of three months or more and is generally a progressive, irreversible loss of kidney
function. CKD exists along a continuum of stages from one to five. Kidney damage
exists at stage two and dialysis typically begins at stage five (Chisholm-Burns et al.,
2013).
Do-not-resuscitate (DNR), also known as a no code – a medical term that
allows a patient to die naturally. Often used for a patient who has a terminal or chronic
health condition. When a patient’s heart stops beating or a patient stops breathing, no
unnecessary or life-sustaining measures are undertaken to prolong the patient’s life
(Santonocito, Ristagno, Gullo, & Weil, 2013).
End stage renal disease (ESRD), which is also known as CKD stage five – an
individual’s GFR is below 15 mL/min/1.73 m2 and dialysis or another form of renal
replacement therapy may be required to sustain life (Chisholm-Burns et al., 2013).
Glomerular filtration rate (GFR) – the amount of blood filtered across the
capillary of the kidney, or the glomerulus, per unit time, based on serum creatinine level,
age, sex, and race (Harrison & Watson, 2011). A normal GFR is more than 90
mL/min/1.73 m2 (Chisholm-Burns et al., 2013).
Nephrologist – a health care provider who studies and deals with the anatomy,
management, physiology, and pathology of the kidneys (Nephrology, n.d.).
Renal replacement therapy – a type of medical therapy that takes the place of
the normal function of the kidneys. Hemodialysis, peritoneal dialysis, and kidney
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transplantation are the three known types of renal replacement therapy (Chisholm-Burns
et al., 2013).
Surrogate decision maker – an individual entrusted to make health care
decisions on a person’s behalf if they are unable to do so. This person should have the
most knowledge about what a person does and does not want in regards to his or her
health and end-of-life care (Wasylynuk & Davison, 2016).
Usual care – asking a patient if he or she has an AD document completed. If not,
the patient is then asked if he or she would like information on one. Information on
forming an advance care plan is sometimes provided, but it is not specific to the care of
patients with CKD. No further steps are identified in regards to ACP or the completion
of ADs.
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Chapter 2
Literature Review
Introduction
Current clinical practice guidelines (CPGs) supported the need for providers to
engage patients in a discussion of goals, preferences, and priorities regarding end-of-life
care through the use of ACP (Agency for Healthcare Research and Quality [AHRQ],
2014). Even in those with CKD, ACP should be targeted to address specific issues that
occur throughout the course of the disease, including initiating, withdrawing, or
withholding dialysis therapy (Renal Physicians Association & American Society of
Nephrology, 1999; AHRQ, 2015). A review of the literature also supported the need for
this intervention as a routine process in the care of all patients with CKD. However,
current data demonstrated a lack of implementation specific to those with this condition
despite the known benefits for all involved.
A literature review was conducted using the Cochrane Library, CINAHL,
EBSCOhost, MEDLINE/PubMed, and Ovid. Search terms included: advance care
planning, advance directive, chronic kidney disease, culture, dialysis, end-stage renal
disease, kidney failure, Native American, renal, and renal insufficiency. Databases were
searched from the years 2011 to 2016. The United States Preventive Services Task Force
(USPSTF) and the Agency for Healthcare Research and Quality (AHRQ) were searched
for relevant CPGs. Search terms included: advance care planning, chronic, dialysis, and
renal. Relevant guidelines were searched from the years 2011 to 2016.
Inclusion criteria for the research studies and CPGs for this literature review
included peer-reviewed articles, written in the English language, consisted of patients 18
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years of age and older, and involved an ACP intervention to determine the effect on
patient and family outcomes and/or the completion of ADs. Articles and CPGs were
excluded if they studied the effects of an intervention targeted to health care providers or
persons younger than the age of 18, utilized a computer-based intervention, were a study
protocol, and were not research based. Together, the combined searches yielded 568
articles that was limited to 20 documents based on the specific exclusion criteria that
answered the PICOT question listed above. Appendix F lists the literature review
methods table.
All retained articles were appraised using the John Hopkins Research Evidence
Appraisal Tool (Dearholt & Dang, 2012). This model assigns a level of evidence, level I
– V, to each article based on study design. The level of evidence assigned to an article is
synonymous with the strength of the article. The highest level of evidence, level I
articles, include randomized controlled trials (RCT) and systematic reviews of RCTs,
both with and without meta-analyses. Level II evidence consists of quasi-experimental
studies. Next, level III is composed of non-experimental studies and qualitative studies.
Level IV contains expert opinion included in CPGs and consensus panels. Finally, level
V is literature reviews, quality improvement projects, and case reports (Dearholt & Dang,
2012).
The John Hopkins Research Evidence Appraisal Tool also assigns each article a
quality grade, in letters A – C (Dearholt & Dang, 2012). Grade A articles are of the
highest quality and contain consistent and generalizable results, a sufficient sample size
for the study design, adequate control, definite conclusions, and consistent
recommendations. Grade B articles, good quality, are defined by reasonably consistent
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results, sufficient sample size based on study design, some level of control, fairly definite
conclusions, and reasonably consistent recommendations. Finally, grade C articles, low
or major flaw, consist of little evidence with inconsistent results, insufficient sample size
for the study design, and no definitive conclusions (Dearholt & Dang, 2012).
CPGs were appraised using the Agree II Instrument (Agree Enterprise, n.d.). The
Agree II Instrument assesses for variability in CPGs, evaluates the quality of CPGs, and
provides a strategy for the development of these guidelines. This tool consists of 23
items categorized into six domains: scope and purpose, stakeholder involvement, rigour
of development, clarity of presentation, applicability, and editorial independence.
Finally, two assessment questions are asked of the appraiser to rate the ability to use the
CPG in practice. This instrument aims to greatly improve the quality of health care
through the rigorous appraisal of CPGs (Agree Enterprise, n.d.). An evidence table was
developed to display the level and quality of evidence, sample, setting, participants, type
of study design, intervention, results, strengths, and limitations (see Appendix G).
Evidence Findings
This literature review focused on an ACP intervention for patients with CKD
stages four and five. Based on the developed PICOT question and the inclusion and
exclusion criteria listed above, outcomes desired included an increase in knowledge of
the ACP process, an increase in ACP discussions with patients and family
members/caregivers, and an increase in the frequency of AD completion. Literature
found focused largely on qualitative and descriptive outcomes with this population,
which strengthened the need for both a quantitative and qualitative focus for this DNP
Project.
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The 20 chosen studies were reviewed and critically appraised to determine the
level of evidence. The John Hopkins Research Evidence Appraisal Tool classified the
articles as three in level I, three in level II, 11 in level III, two in level IV, and one in
level V. Two studies were appraised as low quality or C evidence. One of these studies
was included due to the nature of the study design (quasi-experimental) and the lack of
the availability of this type of results with this topic. This study never discussed the
reliability and validity of the study instruments, which decreased the potential quality of
the findings (Kirchhoff, Hammes, Kehl, Briggs, & Brown, 2012). The second article was
included due to the type of study group and the ability to show the benefit of ACP in a
number of different patient populations (Colombian, Mexican, and Puerto Rican women)
(Carrion, Nedjat-Haiem, Martinez-Tyson, & Casteñeda, 2013).
Two CPGs were appraised using the Agree II Instrument. Based on the results,
both were of high quality, 4/7 and 5/7 respectively, and were appropriate for use in
practice (Renal Physicians Association & American Society of Nephrology, 1999;
AHRQ, 2014; AHRQ, 2015). One of the original CPGs found for this project was
developed in 1999 by the Renal Physicians Association and the American Society of
Nephrology. This document has subsequently been updated in 2010 and re-affirmed for
practice in 2013. Both documents were used in this literature review and throughout the
DNP Project (Renal Physicians Association & American Society of Nephrology, 1999;
AHRQ, 2015). The specific findings are grouped and synthesized below.
Efficacy of ACP. The AHRQ CPG (2014) recommended using a structured ACP
process in patients with conditions for which death within the next year would not be
unlikely, any patient with a chronic illness, and any patient over the age of 55. It is easy
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to see that a patient with CKD, the population component of the PICOT question, fits
many of these requirements. However, even if their death is not likely within the next
year, ACP can and still is a beneficial process for these patients. The findings of two
meta-syntheses stressed the necessity of answering the developed clinical question with
both structure and communication. It was less important the type of intervention utilized
but more or less that an intervention targeted to ACP took place (Luckett et al., 2014;
Oczkowski, Chung, Havney, Mbughaw & You, 2016). Developed CPG
recommendations provided a valid and reliable starting point for intervention tools that
enhanced the efficacy and use of ACP today and resulted in positive outcomes, even in
patients with CKD (Renal Physicians Association & American Society of Nephrology,
1999; AHRQ, 2015).
ACP is a process that cannot be successfully completed in one single office visit.
White et al. (2014) stressed this concept by reinforcing that ACP was an allencompassing process that should consist of an ongoing conversation between a
competent adult, his or her family, and health care professionals about one’s future goals
of care. Opportunities to enhance and increase the use of ACP exist at every office visit
and should be addressed at each point of contact in the health care system. Harrison &
Watson (2011) implemented a nurse-led palliative care clinic that involved meetings with
the patient and/or family members in a series of sessions over a one year time frame.
Patients were exposed to end-of-life issues earlier in the disease process, explored fears
about the future, and were given opportunities to make necessary decisions with their
family or caregivers. Family members felt more in control, had a better idea of the
disease progression, felt more prepared for the future, and were less anxious about the
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end-of-life process after these series of meetings (Harrison & Watson, 2011). At the very
least, an ACP discussion should be implemented annually with those with a chronic
condition or when a patient transitions to the next stage of CKD (AHRQ, 2014; Bristowe
et al., 2015; Goff et al., 2015).
Completion of ADs. The AHRQ (2014) encouraged all patients to complete an
AD. The dialysis center setting was an appropriate time and place to participate in an
ACP discussion in patients who received hemodialysis. Those who participated generally
did not see any problems completing these end-of-life documents and were more willing
to do so and to participate in a palliative medicine consultation if needed after an ACP
discussion (Amro, Ramasamy, Strom, Weiner, & Jaber, 2016; Felly et al., 2016).
When searching to determine what would be best to answer the PICOT question,
the type of ACP intervention did not matter. The use of structure, communication, and
actual implementation of ACP resulted in positive outcomes. Completion of ADs was
greatly increased, patients were more satisfied with their care, end-of-life care was
congruent with their wishes, and costs were decreased at the end-of-life with the
implementation of ACP (Nicholas et al., 2011; Luckett et al., 2014; Oczkowski et al.,
2016). Overall care of patients with CKD will be greatly enhanced with the long-term
and successful implementation of an ACP discussion.
The patient population of those with CKD varies in both race and ethnicity. It
was important to consider the factors those other than Caucasian or Northern European
descent may have in regards to participating in this intervention that may result in fewer
AD documents completed. African American patients, patients from Australia, and
Hispanic women were less likely to want to complete an AD document. Knowledge of
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what these actual documents were and what an AD meant was the biggest barrier to their
completion (Bullock, 2011; Carrion et al., 2013; White et al., 2014).
Patient benefits. The over-arching purpose of this DNP Project was to provide
patients with an avenue to discuss end-of-life goals before ever needing to make these
critical decisions. A simple intervention of an ACP discussion, similar to the intervention
proposed with this project, showed an improved ability for patients to state their end-oflife wishes, enhanced their capacity to partake in an ACP discussion, reduced patient
conflict, provided better congruence with his or her goals of care, and allowed these
decisions to be more easily handed over to family members (Luckett et al., 2014; Song et
al., 2015; Oczkowski et al., 2016). Wishes were explored earlier in life, future fears were
put to rest, and professional support was provided in a non-threatening environment
(Harrison & Watson, 2011). Essentially, patients were more satisfied with the care
received from their health care providers both during and after participating in an ACP
discussion. These studies support the long-term effects of this PICOT question and the
routine use of ACP in this patient population.
When completed, ADs usually place a great limit on treatment preferences of the
patient. Advance care plans and ADs allow the patient to exactly state what he or she
does not want at the end of his or her life. Congruence of care, again, was another longrange goal of this project but was one that could provide great benefit to all involved.
Kirchhoff et al. (2012) and Amro et al. (2016) showed a large increase in the number of
patients choosing a do-not-resuscitate (DNR) status after the implementation of an ACP
discussion. When patients make that choice, they are more likely to be supported as their
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disease progresses. ACP allowed patients to be informed and satisfied individuals with a
written, fluid document stating their preferred goals and wishes.
Family/caregiver benefits. Family and caregiver benefits were not a direct
outcome of this PICOT question. However, the long-range benefits of this project would
greatly serve to benefit these populations. A simple intervention of ACP resulted in
family members who were more prepared and who easily transitioned through the end-oflife process with their ill family members (Song et al., 2015). Communication was
enhanced with all involved, continuity of care was improved, anxiety was decreased, and
overall knowledge of the entire process increased with the use of an ACP intervention
(Luckett et al., 2014; Oczkowski et al., 2016). Many of these outcomes were similar to
patient benefits from an ACP discussion. Even though these were not direct indicators
that were measured through this project, it was necessary to understand how helpful this
process can be for all involved. The involvement of family members should be stressed
when working with this clinical question.
Culture and health literacy barriers. Both culture and health literacy are
important factors to consider when discussing ACP. Waite et al. (2013) showed African
Americans were less likely to complete an AD. African Americans are a fairly large
population served by the outpatient clinic in this DNP Project. It was necessary to
understand this barrier prior to the implementation of this intervention.
ADs are lacking throughout the world (Bullock, 2011; Kataoka-Yahior, Yancura,
Page, & Inouye, 2011; Carrion et al., 2013; Waite et al., 2013; White et al., 2014). The
large number of individuals with CKD stressed the need to intervene with structured ACP
discussions. In addition, this project was targeted to all individuals to ensure those of
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different races and ethnicities were included in this intervention. Several studies focused
on a lack of patient and provider knowledge of the ACP process as the major barrier to
participating in this intervention throughout the world, including persons in Australia,
Ireland, Thailand, and those of Asian Islander and Hispanic descent who were living in
the United States (Artsanthia, Mawn, Chaiphibalsarisdi, Nityasuddhhi, & Triamchaisri,
2011; Kataoka-Yahior et al., 2011; Carrion et al., 2013; Collins & Lehane, 2013; White
et al., 2014).
One’s culture affects many aspects of health care, including the illness
experience, the response to illness, access to health care services, utilization of health
care services, and interaction and communication with health care providers. The Native
American population is plagued with CKD almost twice as often as the Caucasian
population (Walton, 2011). Similar to other racial and ethnic minorities, cultural
awareness is essential when caring for this population. Family is an important aspect of
the Native American population and this stressed the need to involve family members or
caregivers in the ACP process. Discovering the narrative story of the patient may also
help further divulge into his or her illness course. Spirituality, prayer, and the community
are common components of health care of this population and should be integrated into
care plans whenever possible. Each individual is different in regards to what one wants
and does not want at the end-of-life. Oftentimes, it is demonstrating an open and honest
lack of understanding of the culture that will enable the patient to express his or her
wishes. Walton (2011) showed increased exposure to the cultural group was the best way
to understand one’s thoughts and feelings. The use of prayer, spirituality, and traditional
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health ceremonies should be encouraged with the Native American culture if at all
possible (Walton, 2011).
Health literacy directly relates to the knowledge a person has of his or her disease,
its progression, its treatment options, and the ACP process. The health care professional
must be aware of how much a patient does and does not understand in regards to his or
her health and condition in order to successfully answer the PICOT question and in order
to modify the intervention to fit each individual. The health literacy of the sample
population was not directly assessed in this study. However, it was important to address
how much each patient understood at the time of the intervention and to take the time to
address all questions a patient had in regards to the CKD disease process. The
intervention tools used in this project were at a high readability level and this stressed the
need to devote adequate time to help each patient understand the process of ACP.
Waite et al. (2013) identified that those with a higher health literacy had higher
rates of AD completion. The intervention to answer this PICOT question was
implemented on an individualized level. A person’s health literacy was more deeply
understood at the time of the intervention. Using health literacy, an ACP discussion can
be personalized to the patient’s level of knowledge if necessary. Understanding the key
characteristics of culture and health literacy enabled this PICOT question to be more
deeply understood and successful conclusions to be reached.
Health care resource utilization. Health care costs and the admission for use of
health care facilities were not direct outcomes that were measured with this clinical
question. However, a long-range goal of a structured ACP discussion and an increase in
the number of developed ADs could result in a decrease in both of these concepts. ADs
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and participation in an ACP discussion, when developed and utilized appropriately,
usually placed a limit on the care a patient desired to receive at the end-of-life. This
resulted in an overall decrease in health care costs, hospitalizations, and even usage of
emergency room services (Nicholas et al., 2011; Oczkowski et al., 2016).
Suggestions to improve ACP. ACP was an inconsistently used process in the
care of all patients with a chronic health condition (Artsanthia et al., 2011; Bullock, 2011;
Carrion et al., 2013; White et al., 2014; Bristowe et al., 2015). An intervention targeted
to ACP aimed to improve the usual care provided and helped to address and solve the
developed clinical question. Frequent outpatient appointments become the standard of
care for patients with a chronic health condition such as CKD. These visits allow trust to
be developed and a relationship to be established between the patient and the health care
provider. A conversation initiated early on in the disease process, such as at the time of
diagnosis, and initiated by a person the patient can speak freely with, such as a
nephrology Nurse Practitioner (NP), resulted in the most achievable outcomes for this
project. A close, supportive, and trusting relationship with a health care provider was one
of the most stressed and necessary aspects of successful ACP. An active ACP discussion
benefited the patient by enhancing satisfaction with the overall care provided and also
allowed the provider to honor the patient’s wishes at the end-of-life (Bristowe et al.,
2015; Goff et al., 2015).
Usual care of patients with CKD in this outpatient clinic did not routinely involve
an ACP discussion. For this reason, both patients and health care providers were
unaware of the potential effects ACP could have for this patient population. This alone
may have made them unwilling to participate in this project (Artsanthia et al., 2011).
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Knowledge deficits were a major barrier to the use of ACP, even with family members of
patients with CKD. Community awareness was raised and health care providers were
trained to help focus on this necessary process by implementing an intervention focused
on ACP (White et al., 2014). This DNP Project firmly stressed the implementation of
ACP in patients with CKD brought about by a trusting health care provider.
A standardized, validated, and reliable process of implementing ACP resulted in
the most achievable outcomes for patients. A well-developed CPG states five questions
that should be asked routinely in the ACP process of all patients with CKD:
1. If you become unable to make decisions for yourself, whom do you want to
make decisions for you?
2. If you had to choose between being kept alive as long as possible regardless of
personal suffering or living a shorter time frame to avoid suffering and medical
procedures such as breathing machines and feeding tubes, which would you pick?
3. Under what circumstances, if any, would you want to stop dialysis?
4. Under what circumstances, if any, would you not want to be kept alive with
medical means such as cardiopulmonary resuscitation, a feeding tube, or
mechanical ventilation?
5. Where do you prefer to die and whom do you wish to be with you when you
die? (Renal Physicians Association & American Society of Nephrology, 1999;
AHRQ, 2015, pp. 47)
Evidence Summary (Recommendations for Practice)
One of the most common themes obtained from the literature review was an
overall lack of knowledge of the ACP process for many cultures, ethnicities, and health
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care diagnoses. An increase in knowledge greatly enhanced both patient and family use
of this service (Artsanthia et al., 2011). Patients, and even family members, were
generally willing to partake in ACP once offered but it must be delivered by a health care
provider or person he or she can rely upon in a culturally competent manner (Goff et al.,
2015). Patients with CKD stages four and five have a chronic health condition with
obvious treatments, goals, and plans of care. Although the literature was certainly
lacking in regards to this specific diagnosis, the needs of these patients should be
addressed with a structured ACP process which includes an individual trusted by the
patient, the patient, and a family member or close friend.
In summary, an ACP process specific to this group of patients with CKD is
necessary to address their end-of-life goals, future decisions, and health-related issues
consistent with this condition. ACP should be a routine process in the care of all patients
with CKD. Finally, ACP should involve a family member or trusting individual and be
communicated with a health care provider.
Gaps in the Evidence
Several gaps were identified in this literature search despite the above research
findings. First and foremost, a tool used during implementation of an ACP discussion
was very difficult to find. Many studies discussed an intervention was utilized but never
provided a means of re-producing their study. This literature review was unsuccessful in
finding any specific intervention tools or project protocols that could have been used as
the basis for or as a guide to this DNP Project. Next, in all of the literature found, few
studies directly studied the effects of ACP specific to those of the CKD population. A
majority of the data found was in the form of qualitative data and this was a slightly
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different approach than was desired for this DNP Project. While these results were still
beneficial to this patient population, it was difficult to correlate an effect to a project that
hoped to achieve both significant quantitative and qualitative results. In addition, CKD
patients are unique in regards to their end-of-life needs. Treatment options for this
chronic condition, such as dialysis or transplantation, are very limited and are often only
approached with this group of patients when the disease progresses. Withdrawal or
continuation of this treatment can be the difference between life and death for these
patients. Patients without this chronic condition may never have to consider these
options and these topics should be removed from their ACP process unless it is truly
needed. For this reason, it was important to implement an intervention specific to this
group discussing dialysis and other forms of renal replacement therapy. A lack of these
interventions was found despite the great need that exists for this population. A
standardized process to better implement ACP was lacking in all groups and this was
easily seen in the above literature review.
Evidence-Based Practice Model
The Iowa Model of Evidence-Based Practice to Promote Quality Care was the
basis for this DNP Project. This model has been revised a number of times with the most
recent update in 2015 (see Figure 1). The University of Iowa Hospital & Clinics model
provides a guideline for implementing research into nursing practice. Nurses and other
health care staff can make meaningful decisions that result in improved patient outcomes.
The model is not a one step process but instead consists of multiple phases with several
feedback loops. Today, current evidence helps to guide nursing actions. The Iowa
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Model stresses the use of the best evidence throughout its multi-step process (Titler et al.,
2001).
The Iowa Model was the evidence-based practice change model used at the health
care institution where this DNP Project was implemented. This factor allowed the project
to be more easily accepted and disseminated into practice. This model was chosen for its
ease of use, its practicality when addressing a clinical problem, and its effectiveness with
problems of similar interest. An identified need existed to routinely adopt the use of ACP
in patients with CKD stages four and five. The steps of the Iowa Model allowed this
change to be addressed and implemented successfully in an effective problem-solving
process.
The steps of the Iowa Model are detailed below. First, the practice question must
be developed by identifying trigger issues and opportunities (Titler et al., 2001). CKD is
a highly prevalent condition yet few individuals had participated in the unique process of
ACP or had formulated an AD document stating their preferred wishes for the end-of-life.
Discussion with nephrology health care providers and personal experience of the DNP
Project coordinator triggered the development of this project to enhance continuity and
quality of care at the end-of-life and to decrease stress for both patients and family
members. A gap existed in the routine care of patients with chronic health conditions.
ACP is a standard of care that all patients should undergo, especially those with CKD.
Next, the question or purpose of the change must be developed to help guide the
project towards its goal. If the identified issue is a priority, the process can continue on.
If not, other trigger issues must be considered (Titler et al., 2001). The guiding PICOT
question was developed at this point in the project. This question served as the basis for
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the remainder of the project, listed the detailed specifics of the project, and identified the
over-arching goal of the project. Then, a team was developed to help focus the clinical
question, evaluate evidence, and design and evaluate the practice change (Titler et al.,
2001). Stakeholders are necessary to help implement a successful change. The key
stakeholder in this DNP Project was a nephrology NP. This individual agreed with the
identified need to target patients with CKD stages four and five with an ACP discussion
and agreed to help implement this project in the clinic setting. The nephrology NP was
not specifically trained in the process of ACP but she did have a long-standing history of
working with the CKD population and was well-versed in motivational interviewing and
conversation with patients of all ages. As this project progressed, this person was able to
help determine if and when changes needed to be made to the intervention and helped
evaluate the effectiveness of the practice change.
A literature review is the next step to undertake in the Iowa Model. This is done
to help assemble, appraise, and synthesize the body of evidence. If there is sufficient
evidence, the change can continue. If not, feedback loops exist to redesign the change or
formulate another, more important practice change (Titler et al., 2001). A literature
review was described in detail. Using several databases, information was gathered to
assess for the effectiveness of ACP in patients with CKD. However, a gap was found in
regards to available evidence in this category. While this may represent a great barrier to
implementing this change, it was identified that a large body of research exists in regards
to ACP with other patient populations. This sufficient evidence strengthened the need for
this project and helped to provide a basis for this practice change. The change continued
and the intervention was implemented.
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The change is designed and piloted after it has been evaluated. Based on the data
collected, a determination is made regarding the project. A conclusion is reached
whether the change is appropriate for adoption into clinical practice. On-going
evaluation and revisions take place as necessary throughout the process to help sustain
the change and ensure effective results are achieved (Titler et al., 2001). Chapter three
lists the detailed methods, procedures, tools, and statistical approach that were used with
this project. Data was collected and assessed for statistical significance after the
intervention had been implemented for a time period of three months. Based on these
results, conclusions were reached as to whether ACP was effective in patients with CKD.
This DNP Project’s purpose was to achieve a clinically significant change in the
knowledge of the ACP process, in the number of patients and/or family members
participating in ACP discussions, and in the number of AD documents completed with
the sample population.
The last important step is dissemination into practice to share the findings and
help others implement the same change, despite the results (Titler et al., 2001). Chapter
four of this project discusses the exact findings and chapter five forms conclusions for
future practice. It was the goal of this project to provide others with valid data and results
that guided ACP as a standard of care in the management of patients with CKD. Just as
this project was guided by research and data not specific to those with this condition, this
project also served as the basis for the care of all patients.
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Figure 1. The Iowa Model Revised: Evidence-Based Practice to Promote Excellence in
Health Care. Used/reprinted with permission from the University of Iowa Hospitals and
Clinics. Copyright 2015.
Theoretical Approach
Viktor Frankl’s Theory of Meaning (1938) guided the theoretical approach to this
DNP Project. Essential to human nature is the question: Why am I here? This question is
necessary but should be answered by the individual alone. Even in patients who have
been diagnosed with a chronic disease, there remains a will to live in each and every
individual. The Theory of Meaning hopes to divulge this meaning and determine what
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can be done to help the patient achieve meaning in life. Internal conflict is a normal,
natural process and is also part of this theory. Four recommendations exist in this theory:
a person’s search for meaning is the primary motivation of life; a person is responsible
for the meaning of life; a person may find meaning in life even in the face of a hopeless
circumstance; a life offers meaning in every moment (see Figure 2). This theory has been
used successfully in many other areas of health care and is often the basis for working
with those with chronic illnesses (Frankl, 1984).
The most unique reason why this theory fits into this DNP Project is at any point
in life, the individual’s meaning of life may change (Frankl, 1984). Those with any
chronic disease, but especially CKD, can benefit from discovering their true meaning in
life. Herein lies the necessity to partake in an ACP discussion and complete an AD.
Starting this discussion and involving family members or close friends allows the patient
to truly ponder what it is he or she wants for his or her life. Long-term goals can be more
realistically set without other unnecessary stressors, such as a major health crisis,
influencing his or her decision. The ultimate purpose of this DNP Project was to clarify
the desires, wants, needs, and goals for patients with CKD and to avoid difficult decisions
and a death incompatible with their wants and goals. The patient’s true meaning of life
was discovered and their individualized treatment plans were developed from this
meaning through an ACP discussion. As was discussed in the literature review, the ACP
process needs to occur over the course of several office visits and should also be revisited
on a regular basis. Having an open and honest discussion with the patient was the first
step and this was where ACP fell into place with these patients.
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Life purpose is the ultimate goal to be achieved with the Theory of Meaning
(Frankl, 1984). This allows a person to feel called and dedicated to what one does.
Essentially, it is helping making the world a better place through actions. An individual’s
life purpose is unique and must be explored before any complicated and stressful
decisions can be successfully made (Frankl, 1984). When implementing an ACP
discussion, a health care provider will need to help the individual determine what it is
they want to live for and what it is they want to accomplish. Patients with CKD are
vulnerable due to the irreversible nature of the condition but it was still necessary to help
them divulge the true meaning of their life. A trusted health care professional remains
the most competent individual to start this discussion. This necessitated the need for this
project to be undertaken in the outpatient setting.
Freedom to choose is the second main component of the Theory of Meaning
(Frankl, 1984). The freedom to choose exemplifies the process of choosing which
options a person has control over. It clearly explains when a person is presented with two
options, why one person chooses a certain option (Frankl, 1984). Again, this is a very
individualized process and is based on one’s attitude. An individual’s life purpose can be
more easily met in an ACP discussion by helping the patient explore those attitudes and
choose what he or she wants for his or her last few days of life. A patient who feels in
control of his or her actions is more likely to trust the health care provider who supports
this practice and remain consistent with his or her goals and wishes at the end-of-life.
Human suffering is the final component of Frankl’s theory (Frankl, 1984). In line
with each of the other components of this theory, what causes suffering for one person is
very different from another. Suffering is an all-consuming experience, comprising an
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array of emotions. However, unique to suffering is not the exact meaning of the
experience but how one responds to the situation that helps the individual progress
through the Theory of Meaning (Frankl, 1984). CKD is a diagnosis that triggers
suffering in any individual. In many cases, the suffering is prolonged and the patient is
instead confronted with an array of issues when a health crisis occurs. Discovering what
causes suffering in a patient is essential and this is a key component of an ACP
discussion. The cause of suffering can be eliminated and the patient can be allowed to
respond how he or she chooses. Together with life purpose and a freedom to choose, an
ACP discussion stimulated these concepts to be brought forth and the patient was allowed
to experience a greater quality of life consistent with his or her goals and wishes. The
Theory of Meaning is an all-encompassing process that successfully brought forth the
real need for ACP in patients with CKD.

Figure 2. The Theory of Meaning. (Smith & Liehr, 2014, p. 97)
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Change Theory
James Prochaska’s and Carlo Di Clemente’s Transtheoretical Model (TTM)
served as the guiding change theory for this DNP Project. The principle behind this
model is an individual progresses through five specific stages when attempting to change
a behavior, regardless of what the behavior is. The five stages of changes are:
precontemplation, contemplation, preparation, action, and maintenance. Transitioning
from one stage to another helps an individual achieve a successful behavior change but it
is also common for a person to go back and forth between theses stages, such as is
depicted in the spiral model in Figure 3 (Prochaska, DiClemente, & Norcross, 1992).
Key concepts from psychotherapy and previous works in behavior change helped
Procashka and Di Clemente to invent this theory in the early 1980s. This theory was
initially derived while helping individuals quit smoking. Since that time, the TTM has
been used successfully in helping others adopt change in many health related behaviors,
such as alcohol use, anxiety and depression, eating disorders and obesity, and medication
compliance (Prochaska, Redding, & Evers, 2008).
The TTM was utilized when attempting to elicit a behavior and knowledge
change from patients with CKD in regards to ACP. End-of-life decision making is a
complex process and can involve a fluctuation between the individual stages included in
the TTM. As health care providers come to understand the process of behavior change
and determine what stage each individual is in, specific strategies and interventions can
be utilized to help the patients reach the latter phases of action and maintenance. The use
of the TTM in regards to the process of ACP is described below.
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The first stage of the TTM is precontemplation. An individual in the
precontemplation stage has no intention to change the behavior in the foreseeable future.
Essentially, they are unaware that a problem exists (Prochaska et al., 1992). Patients with
CKD without an AD or those who have never participated in ACP before have no
knowledge of the benefit this process could have on their end-of-life goals. This could
occur for many reasons, such as a lack of knowledge of the ACP process or a lack of
knowledge of the correct use of ADs. However, whatever the reason as to why the
patient was in the precontemplation stage, it did need to be brought to the patient’s
attention what the behavior to change was and why it was beneficial to change. This
stage of the TTM focused on education of the individual during the office visit with the
nephrology NP and other support persons to enhance a patient’s overall knowledge. This
brought the idea of a behavior change to the forefront of the person’s mind.
The second stage of this model is the contemplation stage. This stage involves an
individual who is aware that a problem exists. This person is seriously thinking about
making the identified change but has yet to make a commitment to act. The
contemplation stage involves a person weighing the pros and cons of changing the
identified behavior and the proposed solution (Prochaska et al., 1992). Education of the
process of ACP and the completion of ADs resulted in a person who was aware of the
process and actively thinking about participating in this intervention. Internally, the
individual needed to think about what they wanted to experience at the end-of-life, who
they wanted to have this discussion with, and if they were ready to partake. A person can
remain in this stage for any period of time, heavily weighing the pros and cons of the
proposed behavior change. Similar to the first phase of this model, this phase also
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focused on individual education with the nephrology NP and allowed the individual
adequate time to make the commitment to change.
The third stage of the TTM is preparation. This stage combines components of
intention and behavior. Persons in this stage are intending to take action within the next
month but have not previously made this same change within the past year (Prochaska et
al., 1992). An individual was made more aware and more knowledgeable of the process
of ACP with the intervention tool, which helped the patients to progress to this stage.
During successive office visits that involve ACP, the patient can continue to strive to
reach this stage and be able to state exactly what his or her wants, needs, and desires for
his or her end-of-life care are. An individual in the preparation phase of ACP formulated
their own AD document and discovered their true meaning in life, as is in line with
Frankl’s Theory of Meaning. Persons in this stage understood the importance of the
behavior change and were willing to reach the next stage.
The next stage involves action. Action is the stage that involves the actual
behavior change. Individuals here modify their behavior or environment in order to
overcome their problems. This stage is where visible actions occur but this is not reached
without a great amount of time, dedication, and energy from the individual (Prochaska et
al., 1992). The action stage of this intervention involved completing the intervention tool
and having a thorough discussion with one’s family members, close friends, or health
care providers. Action was acknowledging that a behavior change was needed and
actually carrying out that change. This stage was not easily reached but was one with the
greatest reward for the patient as a person determined what it was he or she wanted for
his or her end-of-life care.
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Finally, the maintenance stage is reached. This stage involves a person working
to prevent relapse. Oftentimes, this stage is never ending and an individual must
continually work to sustain the behavior change (Prochaska et al., 1992). The individual
completed the intervention tool, had a discussion with the nephrology NP and/or his or
her family members, and upheld his or her decisions in his or her daily life. The static
process of ACP allowed for an individual to go back and forth between the various
phases, as is an important component of the TTM. If, throughout future office visits or if
a major change in life occurs, a person can go back to the preparation phase, determine
what he or she wants to change, and then successfully move through the action and
maintenance phases as necessary. It is important to understand that this model relies
heavily on education in order to help a person adopt a successful and long lasting
behavior change.

Figure 3. Transtheoretical Model. (Prochaska et al., 1992, p. 1104)
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Chapter 3
Method and Procedures
Introduction
This DNP Project was developed to address the aforementioned proposed PICOT
question utilizing a quality improvement approach in the design phase of the Iowa Model.
Based on the needs of the health care institution and the DNP Project coordinator
experience, the setting and sample were chosen. A five question validated and appraised
CPG was utilized as the main intervention and served as the ACP discussion guide
throughout this project. Changes in patient knowledge of the ACP process were also
assessed utilizing a six question pre-test and post-test document. Below is a detailed
structure of the procedure and analysis, based on various potential impacts,
considerations, barriers, and stakeholders.
Design/Approach
This project was focused as a quality improvement project. Quality improvement
projects are based on an organized, evidence-based, systematic process designed to
ensure patients are provided care that is addressed in a reliable manner. Quality of care
provided to patients is enhanced due to current evidence that has been implemented into
practice throughout other projects such as this. A working hypothesis is necessary in a
quality improvement project. Projects of this type are usually low risk to a patient and
are becoming more routine in today’s clinical practice (Melynk & Fineout-Overholt,
2011).
The literature review completed showed the necessity of integrating ACP into
routine health care practices. Several studies have shown the effectiveness this process
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has had on patients with other chronic conditions but data was lacking in regards to those
with CKD. Using successful interventions and validated CPGs, ACP was used to
improve the care of patients with CKD. A clinical hypothesis or PICOT question guided
this quality improvement project. This process has the potential to translate to other areas
of health care as a more routine and effective process.
This quality improvement project involved a retrospective chart review. The
retrospective chart review served as the comparison group for this DNP Project. The
population who received the intervention was a non-randomized convenience sample of
patients with CKD stages four and five who were seen in the clinic setting by a
nephrology NP. Both samples were similar in characteristics yet were a different group
of individuals. A detailed discussion of the tools and procedures this project involved is
described below.
Setting
The project setting was an urban Midwestern nephrology clinic located in a town
of approximately 180,000 people (U.S. Department of Commerce, 2015). The clinic was
attached to a main hospital campus. Specialized nephrology care was provided to adult
patients 18 years of age and older who came from both rural and urban backgrounds.
Many patients traveled over 100 miles to be seen in this clinic. Time of travel for
patients averaged between two and four hours; however, some patients drove up to six
hours to be seen in this clinic. Patients also traveled from various surrounding states,
including Iowa, Minnesota, and Nebraska, to utilize the services provided in this setting.
Telemedicine services were provided to remotely access patients in rural settings in both
South Dakota and Minnesota. Most patients were middle class but income levels varied
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from the very poor to the very wealthy. Those with both acute and chronic renal issues
were seen in this clinic (A. Saeger, personal communication, June 21, 2016).
This clinic was staffed by four physicians (including three Medical Doctors and
one Doctor of Osteopathy), two NPs, four registered nurses, one licensed practical nurse,
and two schedulers/receptionists. No interdisciplinary team members were employed in
this clinic. A social worker and dietician were available by telephone but they did not
routinely see patients in the clinic setting unless a specific need was identified by a
provider. A clinic manager was available to provide notary services at the time of AD
completion.
Combined, the six health care providers had more than 40 years of experience in
the nephrology setting, including patients on both hemodialysis and peritoneal dialysis.
A specialized area of interest of all providers was hypertension management. Most
providers were educated in urban areas with a focus on nephrology management. Nine
exam rooms were utilized between the six providers. Approximately 60-80 patients were
seen each week by all of the providers. The key stakeholder, one nephrology NP, in this
project saw approximately 10-20 patients in the clinic setting each week. Appointment
times varied based on patient diagnosis. New patient appointments averaged 40 minutes
in length while follow-up visits were routinely 20 minutes. Laboratory and x-ray services
were not provided in this clinic. However, a laboratory facility was located in the
basement of the same building and x-ray services were provided at the main hospital
campus (A. Saeger, personal communication, June 21, 2016; K. Jerke, personal
communication, July 5, 2016).
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Sample
The sample for this project was a non-randomized convenience sample of patients
with CKD stages four and five without an existing AD document who were seen in the
clinic by one nephrology NP. Inclusion criteria for the intervention sample included
adult patients over 18 years of age. Patients of all ethnicities and races were included in
the project sample, as well as those of all genders. While English was the major language
spoken among the patients in this clinic, those who were non-English speaking were also
included in the sample. Translator services by the use of phone, iPad, or live interpreter
were available and provided to these patients. One iPad used for translator services only
was available from the clinic receptionist staff. If a trained medical interpreter was
needed, the nursing staff arranged for this service prior to the patient’s scheduled
appointment. The informal letter of invitation, informed consent form, knowledge
assessment, and intervention tool were not translated into individual languages. It was
necessary to go through each document with the interpreter service, patient, and family
members to ensure they were knowledgeable of the process, willing to participate, and
were able to actively engage in the ACP discussion. A large majority of the population
seen in this clinic was Caucasian, followed by persons of Native American and African
American descent (A. Saeger, personal communication, June 21, 2016). Cultural
differences were addressed on an individual level. It was the aim of this project to help
an individual incorporate ACP into his or her medical care while also respecting the
cultural beliefs and values one may have. It was hoped that all genders were equally
represented in this DNP Project.
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Due to the many coexisting conditions that occur with CKD, those who received
the intervention had an array of comorbid conditions. Hypertension, diabetes, and
peripheral vascular disease were a few of the most common comorbid health conditions
this sample had. Those with conditions that impair brain functioning and/or limit
decision making capacity (such as dementia and Alzheimer’s disease), however, were
excluded from this sample due to the nature of the intervention and the great need for
adequate decision making capacity to state one’s goals and desires for their end-of-life
care. This was determined based on past medical history or discussion with family
members or caregivers. In addition, patients who already had an AD document were
excluded from the project sample per the health care institution’s request. These factors
were the only exclusion criteria utilized in the intervention.
The comparison sample was patients from one year ago at the time of project
implementation with CKD stages four and five who were seen in the clinic setting by the
same nephrology NP. Patients who were part of the comparison sample were not
included in the project sample. A thorough chart review ensured the comparison sample
and intervention sample did not overlap. Comparison sample data was gathered and
reviewed from January 1, 2016 to March 31, 2016. All patients reviewed were similar in
characteristics to the intervention sample. The inclusion criteria for the comparison
sample was the same as that listed for the intervention group. Comparing these two
groups at the time frame of one year ago limited the influence of extraneous variables and
other biases that may have occurred with one sample and not another, thereby providing
the most accurate results for this DNP Project. The estimated sample size of this project
was n = 20-30.
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Development of Intervention/Tools
The intervention for this DNP Project was the implementation of a standardized
ACP discussion tool. This intervention replaced the usual care currently received and
allowed patients with CKD to focus on goals of care specific to this patient population.
Five specific questions were recommended by the Renal Physicians Association and the
American Society of Nephrology as being critical to implement in ACP in patients with
CKD (Renal Physicians Association & American Society of Nephrology, 1999; AHRQ,
2015). The five questions were:
1. If you become unable to make decisions for yourself, whom do you want to
make decisions for you?
2. If you had to choose between being kept alive as long as possible regardless of
personal suffering or living a shorter time to avoid suffering and medical
procedures such as breathing machines and feeding tubes, which would you pick?
3. Under what circumstances, if any, would you want to stop dialysis?
4. Under what circumstances, if any, would you not want to be kept alive with
medical means such as cardiopulmonary resuscitation, a feeding tube, or
mechanical ventilation?
5. Where do you prefer to die and whom do you wish to be with when you die?
(Renal Physicians Association & American Society of Nephrology, 1999; AHRQ,
2015, pp. 47)
From these questions, a one-page document was developed to use as the intervention and
primary tool for this project. The Renal Physicians Association granted permission to use
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this document as part of this DNP Project (see Appendix I). Appendix L shows the
specific document used.
The Agree II tool was used by the project coordinator and three other DNP
students to appraise the CPG (Agree Enterprise, n.d.). All persons were familiar with and
had experience using this tool. The CPG was recommended for use by all four
individuals and was rated, on average, a 5.75/7. This demonstrated the high quality of
the CPG and showed how necessary it was to implement into current practice. In
addition to the overall high average rating received, the overall objectives of the guideline
were clearly stated, systematic methods were used to search for available evidence, key
recommendations were easily identifiable, and the recommendations were specific and
unambiguous (Agree Enterprise, n.d.). The CPG discussed methods used for data
extraction that greatly strengthened the validity of the project and discussed congruence
of the CPG with several nephrology physicians, which also increased the reliability of the
document (Renal Physicians Association & American Society of Nephrology, 1999;
AHRQ, 2015).
A six question pre- and post-intervention knowledge assessment was given to
patients to determine their increase in knowledge about ACP and ADs after the
implementation of the intervention. These questions were adapted from a RCT that
assessed change in knowledge of medical students of the ACP process after a
computerized intervention. These questions were developed through a thorough
literature review and both face and content validity were verified prior to their
implementation (Green & Levi, 2011). Both multiple choice and true/false questions
were included. The six questions were:
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1. An advance directive is a document that:
o Expresses an individual’s medical wishes when that person is unable to
speak for him- or herself
o Determines who will handle one’s financial affairs after death
o Explains one’s rights as a patient
o I don’t know
2. Advance directives go into effect if an individual:
o Gets admitted to the hospital
o Has a terminal medical condition
o Can no longer communicate his or her health care decisions
o I don’t know
3. In general, the best person to serve as an individual’s health care surrogate is
the person who:
o Has the most knowledge
o Is best able to represent the individual’s views
o Has known the individual the longest
o I don’t know
4. Of the following, which is least important for a patient to do regarding advance
care planning?
o Discuss their values and wishes regarding end-of-life care with trusted
family members and friends
o Create an advance directive that explains their goals of care
o Provide their physician(s) with the advance directive
o Use a state-specific living will form
5. Advance care planning is a one-time process and does not need to be revisited
during the course of a patient’s life.
o True
o False
6. If an individual has decision-making capacity and can still speak for him- or
herself, an advance directive does NOT determine which medical treatments they
will receive.
o True
o False (Adapted from Green & Levi, 2011, pp. 88-90)
From these questions, a one-page document was used to assess a patient’s baseline
knowledge prior to the intervention. The same questions were used to assess a patient’s
change in knowledge following the completion of the intervention. Appendices J and K
show the specific documents used.
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Project Procedure
This project transitioned into the implementation phase after obtaining both the
health care organization and university’s Institutional Review Board approval. A
retrospective chart review was completed from one year ago at the time of
implementation to gather information on the comparison sample. The actual chart review
process was conducted during the first week of this DNP Project implementation period.
A chart review was done to determine the number of patients with CKD stages four and
five who were seen by the same nephrology NP who had a documented ACP discussion
and the number of patients who had a completed AD document in their electronic
medical record. These baseline numbers helped to determine the amount of change that
occurred with this project in a similar patient sample seen at the same time of the year
and who were seen by the same provider in the same clinic setting.
One to two weeks prior to project implementation, a meeting was held with the
nephrology NP, clinic manager, members of the nursing staff, and the clinic receptionists
to review the informal letter of invitation, informed consent form, intervention tool, and
pre- and post-intervention knowledge assessment document. A routine process of
implementing all parts of the intervention were discussed. These staff members were
provided with an algorithm document to assist in the process of completing all of the
steps of the intervention (see Appendix O).
Each working day during the three month intervention period, the nephrology NP,
clinic nurses, and receptionists determined from the scheduled patients those who were
eligible to receive the intervention. An asterisk was made next to each eligible patient on
a printed clinic schedule that was placed at the front desk. The nephrology NP and the
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other involved stakeholders were knowledgeable of who was to receive the informal
letter of invitation, informed consent form, pre- and post-intervention knowledge
assessment document, and intervention tool for that day and fulfilled their role in the
intervention as detailed below. The DNP Project coordinator was not readily available in
the clinic setting during the implementation period but checked-in with the nephrology
NP on a weekly basis and was available by telephone if questions or concerns arose.
The clinic receptionists gave each eligible patient an informal letter of invitation
from the DNP Project coordinator (see Appendix M). While waiting to see the
nephrology NP, the patient had time to formulate any questions in regards to the details
of the project. The nursing staff answered these questions while rooming the patient.
The patient then selected one option on the bottom of the informal letter of invitation,
either I agree to participate or I decline to participate. The completed informal letter of
invitation was given to the nurse. All forms, even if the patient declined, were kept in a
locked filing cabinet, only accessible by nursing staff, the key stakeholder, and the
project coordinator. After this step, the nurse then asked the patient if he or she had an
AD document. If the patient did, usual care ensued and the patient was not eligible for
the intervention. The office visit went on as originally scheduled. If the patient did not
and agreed to participate, the intervention would have continued, in addition to the
scheduled office visit for that day.
If the patient did not have an AD document and would have agreed to participate,
the nurse would have provided the patient with the informed consent form (see Appendix
N). The nursing staff would have collected the completed informed consent form from
the patient during the rooming process. These forms would have been stored in a locked
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filing cabinet only accessible by nursing staff, the key stakeholder, and the project
coordinator. After the nurse completed her rooming procedure, the patients who
consented to the intervention would have been given the pre-intervention knowledge
assessment document to gather baseline data of patient knowledge in regards to ACP and
ADs. The assessment tool would have been returned to the nursing staff or nephrology
NP. These assessments would have been stored in the locked filing cabinet only
accessible by the nursing staff, the key stakeholder, and the project coordinator. The
nephrology NP would have then provided the intervention to the eligible and consenting
patients using the developed intervention tool.
The nephrology NP would have had a discussion with the patient and/or
individual(s) who were present at the time of the appointment using the developed
intervention tool. This intervention would have replaced usual care. The patient would
have been encouraged to complete the form at the time of the visit, discuss his or her
wishes with the nephrology NP, or take the form home to discuss with family members
and fill out at a later date. If the intervention tool would have been completed at the time
of the office visit, the clinic manager would have served as the notary to witness the
signing of the AD document. The nephrology NP would have then given the document
to a member of the nursing staff who would have ensured the document was scanned into
the patient’s electronic medical record. A copy would have been sent to the medical
records department and the original document would have been kept in the locked filing
cabinet in the clinic. These forms would have been only accessible by the nursing staff,
the key stakeholder, and the project coordinator.
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Finally, the same knowledge assessment tool would have been given to the patient
in the form of a post-intervention knowledge assessment document. This would have
been given to the patient by either the nephrology NP or any member of the nursing staff.
The patient would have given the completed assessment to either the nephrology NP or
any member of the nursing staff. As similar to the pre-assessment, the post-intervention
knowledge assessment documents would have been kept in the same locked filing cabinet
only accessible by the nursing staff, the key stakeholder, and the project coordinator.
The nephrology NP would have given each eligible and consenting patient an
identifying patient number. This number would have been placed onto the patient’s
informal letter of invitation, informed consent form, intervention tool, and pre- and postintervention knowledge assessment documents. This would have allowed all completed
forms for each patient to be grouped together for a more streamlined approach to data
collection after the completion of the intervention.
The nephrology NP would have been encouraged to document the ACP
discussion in the patient’s progress note in the electronic medical record. If the patient
did not complete the intervention tool at the time of the clinic visit, he or she would have
been encouraged to return the form to a clinic staff member as soon as he or she felt
ready. The same procedure for medical record documentation would have occurred any
time during the implementation period when a patient returned the intervention tool to the
clinic staff members, including scanning the form into the electronic medical record,
sending a copy to the medical records department, and keeping the original form in the
locked filing cabinet only accessible by the nursing staff, the key stakeholder, and the
project coordinator.
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At the end of the three month time period, the patient sample was reviewed to
determine the number of ACP discussions completed and the number of intervention
tools received to help determine the change this intervention had on the sample. In
addition, the change in knowledge from the pre-intervention knowledge assessment
would have been measured against the post-intervention knowledge assessment to
determine the amount of knowledge the patients obtained from participating in this
intervention. As similar to the comparison sample, the same demographic data (age
range of the patient, gender of the patient, race of the patient, and stage of CKD) were
collected with the intervention sample to aid in determining factors which promoted or
hindered this change. Weekly check-ins and discussions with the stakeholders by the
DNP Project coordinator were a necessary process to help identify any changes that
needed to occur, discuss any barriers the nephrology NP or other staff members were
encountering, and review any successes or set-backs the project was experiencing.
Ethical Considerations
This DNP Project was proposed to the health care institution’s Institutional
Review Board and Nursing Research Council for approval (see Appendices B and C).
Once approval was obtained, the project was submitted for approval to the DNP Project
coordinator’s university Institutional Review Board (see Appendix A).
The retrospective chart review data included demographic data as well as the
number of patients who had completed an ACP discussion and the number of
documented ADs. This information was stored in the same locked filing cabinet only
accessible by the nursing staff, the key stakeholder, and the project coordinator. The
intervention tools, pre-intervention knowledge assessments, and post-intervention
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knowledge assessments would have been collected and stored in the same manner
following informed consent. All data was collected electronically and was de-identified.
This project placed a patient at a low risk from an ethical standpoint. An ACP
discussion collects information about sensitive end-of-life issues and asks questions that
could possibly cause psychological distress, discomfort, and anxiety beyond what is
experienced in daily conversation. This project was a necessary component of the care of
patients with a chronic condition, such as CKD, despite the known risk. A patient was
able to withdraw from the project at any time. If this did occur, usual care ensued from
the nursing staff and nephrology NP and the appointment went on as previously
scheduled. There were no repercussions to the patient for withdrawing from the project.
If information needed to be stored for the DNP Project coordinator, it was kept in
the locked filing cabinet in the clinic. This information will be kept for a total of six
years in order to comply with university Institutional Review Board requirements.
Electronic ACP and AD documentation will be accessible by anyone directly caring for
the patient, including nursing staff, health care providers, and the project coordinator.
Health Insurance Portability and Accountability Act (HIPAA) and electronic medical
record accessibility was maintained for this reason.
Projected Analysis
Demographic data collected included the age range of the patient, gender of the
patient, race of the patient, and stage of CKD. This data was analyzed using frequencies
and percentages and aggregate demographic data was displayed. Data was gathered to
assess for the change in the number of patients who participated in an ACP discussion
and/or who had an AD document completed after the intervention. Due to the nature of
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this part of the project and the different comparison group used for analysis, an
independent, or unpaired, t-test would have been used to assess for a statistically
significant change after the completion of the intervention. The two groups were
independent of one another and were different in regards to sample size; hence the use of
the independent t-test. An independent t-test compares the means of two groups of data,
which was the overall objective of this DNP Project. The level of significance, or pvalue, was set at p < 0.05. This specific p-value was chosen over a p-value of 0.1 to
provide more significant data that a true difference was detected in the actual data
gathered.
Data was also analyzed to assess for a change in the level of knowledge patients
have of the ACP process and the use of ADs after the intervention. Due to nature of this
part of the project and the same comparison group used for analysis, a dependent, or
paired, t-test would have been used to assess for a statistically significant change in
knowledge after the completion of the intervention. The two groups were dependent of
each other; hence the use of the dependent t-test. A dependent t-test compares the means
of the same two groups of data, which was also another overall goal of this DNP Project.
The level of significance, or p-value, was set at p < 0.05. This specific p-value was
chosen over a p-value of 0.1 to provide more significant data that a true difference was
detected in the actual data gathered.
Environmental and Organizational Context
The vision of this health care institution is dedicated to improving the human
condition. ACP is a process that can easily help improve the human condition. Helping
patients identify what their goals and wishes are for end-of-life care before a change in
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health occurs, before the patient is unable to make his or her own decisions, or before the
thought even crosses the patient’s mind is necessary to improve and promote a higher
quality of life near the end-of-life. Making patients aware of and presenting them with
their treatment options gives them the necessary tools to consider their wants, needs, and
desires for their last few months. In the end, quality of life is greatly enhanced, all in line
with the goal of improving the human condition.
Courage, passion, and family are three core values of this organization and are
also necessary to consider when implementing this DNP Project. An ACP discussion is
one that few providers undertake today. This conversation involves feelings and
emotions and is oftentimes not what the patient or family members want to hear. It is a
challenging topic to address with patients and often leaves patients, families, and
providers feeling unsettled. Many providers may be unsure of how to bring about this
discussion and instead leave it unaddressed with their patients. Courage is necessary to
present the truth in a caring and compassionate manner. Passion about the topic of early
ACP and the use of ADs is also necessary to implement this project successfully. Passion
is shown by focusing on the patient and/or family during an ACP discussion and helping
the patient identify his or her wants, needs, and desires for end-of-life care. An open,
honest, and trusting relationship between the involved parties is also essential and
embodies passion from all of those involved. Finally, family is another key value to
consider when implementing ACP. Many patients are close to their family members and
are concerned about leaving them with difficult decisions to make. This process helps
eliminate stress and anxiety of those other individuals and also promotes a greater view
of the dying process in light of ACP.
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Discussions with the nephrology NP and the clinic manager provided this DNP
Project coordinator with overwhelming support (K. Jerke, personal communication, May
19, 2016; A. Saeger, personal communication, June 4, 2016). This organization’s
Nursing Research Council also supported this project. The Council identified a lack of a
current work flow, a lack of AD documentation in the outpatient setting, and a lack of a
standardized process of ACP specific to this patient population. This DNP Project’s
purpose was to address and improve all of these concerns, in addition to enhancing
overall patient knowledge of the process of ACP. As this project was implemented,
support from the first two individuals was necessary and also helped to overcome any
barriers that were experienced. This project could not have been implemented alone, and
as a team, successful changes were reached that could then be implemented as a routine
practice throughout the entire clinic and health care organization.
Stakeholders/Facilitators
The key stakeholder for this project was one nephrology NP. She served as the
primary implementer of the intervention tool and helped complete the chart review to
determine changes in ACP discussion rates and AD completion rates. This individual
had a well-rounded experience working with patients with CKD and comprehended the
necessity of this intervention and project. Another stakeholder in this project was the
clinic manager. This individual, again, realized the necessity of this intervention and was
willing to help pilot this project in the clinic setting. This person also served as the
notary to witness the signing of the AD documents if completed in the clinic setting. The
help of these two individuals allowed patients with CKD to achieve improved and more
consistent outcomes with the implementation of ACP.
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The members of the nursing staff and the clinic receptionists were also
stakeholders to this DNP Project. Together, these individuals helped identify patients
who were eligible for the intervention each day. The clinic receptionists gave each
eligible patient an informal letter of invitation at the time of appointment registration.
Then, while rooming the patient, the nursing staff answered any questions the eligible
patients had and collected the informal letter of invitation. These individuals would have
given the informed consent form to the consenting patients, would have gathered the
signed informed consent form, would have completed the steps of usual care, would have
administered the pre- and post-intervention knowledge assessment tool to the appropriate
patients, and then communicated with the nephrology NP whether or not the patient
consented and if he or she had an existing AD document. The nursing staff would have
helped gather the completed intervention and assessment tools. They also would have
ensured the completed intervention documents were placed into the patient’s electronic
medical record. The DNP Project coordinator worked closely with these individuals to
ensure they understood their scope of the project and answered any questions as they
arose.
As this project continued to move forward, the other providers in the clinic helped
to serve as stakeholders of this project. As the nephrology NP began to have these
conversations with the patients she was seeing, the patients of other providers began to
ask about these critical conversations. Through word of mouth and realizing what a
difference this intervention could have on their patients, the interest of the other providers
increased and it is hoped that they will begin to adopt this into their own practice. In
addition, these individuals had personal experiences and ideas or suggestions to improve
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this project. The vast array of knowledge and personal experience of these providers
served to help this DNP Project move forward and achieve successful results.
Finally, the health care institution at which this project was implemented was a
stakeholder to the success of this intervention. The Nursing Research Council of this
organization allowed this project to move forward. The Council hoped for great results
to be achieved that can then be translated to other areas of this organization. A clinical
nurse leader stressed the necessity of the project to the DNP Project coordinator and was
instrumental in launching the idea of this project. The vision of this institution and three
key values, courage, passion, and family, were achieved with this project.
Potential Barriers
Barriers have a potential to occur with any project. Time was a great barrier with
this specific DNP Project. This intervention was implemented for the time frame of three
months, which may not have provided some patients with enough time to make these
sensitive decisions or to identify all of their wants, needs, and desires. As was discussed
in chapter two, ACP is not a one-step process but instead needs to be revisited with each
patient over several office visits. The topics discussed with the five question intervention
tool were a lot for a patient to process in one short office visit. This was another valid
reason why a greater period of time may have been more beneficial to the ACP process.
A longer time period, such as one year, may result in more patients completing the
intervention tools. This may also result in more significant results and as such, would
have a larger impact on this patient population. Due to the time constraints of this
project, that was not feasible. The time frame chosen still allowed for successful results
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to be achieved. Based on these results, it would then be implemented for a longer time
frame and with a larger sample of patients.
The informal letter of invitation, informed consent form, pre- and postintervention knowledge assessment document, and discussion tool all had a very high
readability level, around the 12th grade for all documents. ACP and ADs bring about
very challenging issues, and as such, do require a somewhat higher level of thinking in
order to complete them successfully. For some persons, it may be quite difficult to read
and complete the tools and actively participate in the intervention for this reason. The
nephrology NP completing the intervention needed to consider this aspect during the
implementation. In addition, it was important to also understand that patients may need
some extra time to read and comprehend all parts of the intervention.
This project had multiple steps and processes that required time and attention
from nursing staff. There was a great possibility that steps were missed in the process.
Establishing a buy-in and providing an algorithm of the processes this project entailed
helped prevent any aspects of the project from being missed. Detailed meetings and
discussions both before the start of the implementation period and also during the three
month time frame helped to ensure all steps were being followed and all staff members
were aware of what the expectations were.
The nephrology NP, chosen as the key stakeholder for this project, routinely
rounds on patients in the hospital setting while also seeing patients in the clinic. This fact
served as a barrier as the sample of patients may be somewhat smaller as opposed to a
provider that only sees patients in the clinic setting. In addition, this nephrology NP may
have needed to spend more time with patients implementing the ACP discussion and this
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may have decreased the total number of patients she was able to spend time with in the
clinic setting. Overall, the productivity of the clinic could decline slightly, but the
increase in long-term patient outcomes will override these productivity losses. The clinic
manager was aware of this barrier prior to the implementation of the intervention but was
still willing to help the patients reach better and more consistent outcomes with ACP.
Turnover in the clinic with both nursing and various support staff could also serve
as a barrier to this project. Changes in nursing staff and clinic receptionists during the
course of the project may result in fewer patients being enrolled in the project and less
significant results achieved. In addition, more time may be required to train new staff in
the process of this project and this may also result in fewer patients who are targeted with
the ACP intervention. Again, it was hoped that if this DNP Project was successful in the
outpatient setting, this process could then be implemented in the inpatient setting.
Having a provider who provided care in both settings helped to round out this project and
will allow for easier translation in other settings and with other patient populations.
Finally, as with any project, a lack of patient participation and a lack of patient
buy-in to the necessity of the project was a major barrier that could be encountered. As
was shown in the literature review, many patients lacked knowledge of ACP and did not
see the necessity of completing an AD document. Education is an essential component of
this intervention in order to engage patients to participate and to help them see the
necessity of this project. As the nephrology NP implemented the project with each
patient, questions were answered and the use of ACP and AD documents was addressed.
Fully informed patients are more likely to participate with a trusting health care provider.
However, if a trusting relationship is not first established between these two individuals,
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the project will not be successful. New patients to the clinic undoubtedly require more
time to establish this relationship with the nephrology NP. Nevertheless, these
individuals were not excluded from the sample. The nephrology NP used motivational
interviewing and effective communication skills to establish a rapport with the patients.
The ACP discussion could be undertaken and success could be achieved after this had
been established. These barriers provided potential set-backs to this DNP Project.
However, once they were overcome, significant results could be achieved.
Impact on:
Organization. This DNP Project was directly in line with the vision of the health
care institution at which it was implemented, as was discussed above. ACP helps to
promote the human condition and directly achieves the three values of courage, passion,
and family. Two stakeholders at the participating organization saw the necessity of this
project and were willing to pilot it in one outpatient clinic. As this project progressed, it
was important to involve several key organizational members to engage in and enable
project dissemination. It was hoped that significant results will be achieved to more
easily allow this topic to be translated to other areas of health care. Stressing the
necessity of this project with all involved, educating patients, and involving health care
staff may allow ACP to become a routine process in the care of all patients throughout
this health care organization.
Finances. Costs were incurred to print the informal letter of invitation, informed
consent form, intervention tool, and knowledge assessments but were minimal when
completed in large quantities. A major cost that could occur with this DNP Project was
the increased time the health care provider spent with the patients having the ACP

ADVANCE CARE PLANNING

60

discussion. This may have resulted in less reimbursement received from insurance
companies and federal organizations in addition to less time available to see other
patients. However, the cost savings of an ACP intervention greatly outweighs the costs
incurred. Individuals who participated in ACP and those who developed ADs more often
choose treatment-limiting options. Essentially, a higher quality of life may be
experienced at the end-of-life with fewer invasive treatments, hospitalizations, intensive
care unit (ICU) stays, emergency room visits, and medications needed to promote a
sustainable life.
Diagnosis codes used for Medicare patients are available for initial ACP
discussions as well as each additional 30 minutes spent with a patient in this type of
intervention (Centers for Medicare and Medicaid Services, 2016). ACP is a reimbursable
service for providers yet it was not a routine process in this outpatient clinic. This fact
stressed the need to make ACP a more consistent practice. Providers do understand more
time is necessary to participate in ACP. However, if it is a billable service and they are
reimbursed for their time spent with patients, providers should be more willing to
participate and integrate this practice into the routine care of their patients, especially in
those with CKD.
Policy decisions. If this project is successful at showing the impact ACP can
have on a small sample of patients with CKD, ACP will need to become a routine
practice in the care of all patients with a chronic health condition. For that reason, strict
policies and procedures will need to be developed to guide an ACP discussion if it is
shown to be successful. Key organizational leaders will need to be involved in this
process in order to engage and promote dissemination into health care practices.

ADVANCE CARE PLANNING

61

Quality of health care. The greatest impact of this DNP Project rests on the
improved quality of care that can be experienced with ACP. Patients will benefit the
most from an intervention of this type. Their benefits include a higher quality of care
experienced at the end-of-life, a care that is congruent with their wishes at the end-of-life,
lower cost of care at the end-of-life, fewer hospitalizations and emergency department
visits, and an enhanced relationship with their health care provider. However, family
members can experience a wide array of benefits from the use of ACP. Family members
can have less stress and anxiety about end-of-life decision making and feel more
confident caring for their family member who has developed an AD or participated in
ACP.
Health care providers implementing the practice also benefit from choosing to use
ACP with their patients. They will have a greater connection with their individual
patients and increased satisfaction in taking care of patients who are fully informed,
satisfied, and aware of their diagnosis, prognosis, and treatment options. Finally, as was
discussed in the cost section, a cost savings and a smaller use of resources will result for
the health care institution. In the end, ACP is envisioned to be a routine process for the
health care institution at large. Policy making and changes after this project will ensure
ACP is an expectation for both providers and patients at this organization. Patients will
expect to be asked these questions, to engage themselves in end-of-life decision making,
and to develop goals and desires for their disease process.
Rural or underserved populations. This outpatient clinic served a wide-range
of patients, including those who came from many small rural communities. Those who
live in a rural environment have less access to health care and less health care resources
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to utilize. Individualized patient goals can be tailored based on what treatments are
available in the community or what would be most accessible to the patient. Rural
patients would benefit by having an increased awareness of services and options, which
makes their end-of-life care more congruent with their goals and wants on an individual
basis. The educational component of ACP is essential with all patients, but especially
those coming from a rural setting. A higher quality of life is experienced for these
patients with the help of ACP, even if access to health care and resources is less.
Those with CKD are medically underserved for many reasons, such as a lack of
available dialysis facilities, a lack of successful long-term treatment options, and a high
cost of procedures and medications that only prolong their life for a short period of time.
The use of ACP and the completion of ADs served to help limit these factors. Patients
increased their awareness of all of their treatment options but also chose to forgo such
expensive, extensive, or invasive procedures having the full knowledge of what it all
entails. Again, the educational component of an ACP intervention was necessary to
ensure this process was successful. Patients with CKD who are more informed, educated,
and satisfied experience a quality of life congruent with their wants, needs, desires, and
treatment prognosis. ACP helps to even the playing field for this underserved population
and enhances quality of life without going through any unnecessary procedures, should
the patient desire.
Non-English speaking patients are also an underserved population. These persons
lack knowledge and literacy of health and health care and often do not seek health care
due to the language barrier that exists. Often times, when health care is sought, it is in
emergency situations. Health care providers do not have the knowledge of what a patient
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would want at the end-of-life if he or she has not sought health care before. Language
barriers should not be a reason to not implement ACP in this patient population. These
patients need more time to understand the components of end-of-life care but it is
essential to provide them with this service. ACP with this patient population may result
in more informed and educated patients who are able to access the health care system at
all stages of life, even during the end-of-life.
Summary
This DNP Project had the ability to reap great rewards for all of those involved.
Utilizing a quality improvement approach with a retrospective chart review and the
experience of a nephrology NP, patients with CKD stages four and five were given a
valid and reliable ACP tool based on recommendations from a CPG. It was the goal that
the number of patients participating in an active ACP discussion and those completing an
AD document would increase with this one-on-one individualized intervention. Overall
knowledge of the ACP process will be increased with the implementation of this
intervention. Patients will experience a greater quality of life at the end-of-life, care
congruent with their wishes, and a more dignified dying process with ACP. Patients with
CKD will feel more prepared for the road that lies ahead and will be able to decide for
themselves what they want for their last few days. This health care organization’s values
of courage, passion, and family were met with the implementation of an ACP
intervention specific to those with CKD.
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Chapter 4
Findings
Introduction
All data collected for this project was gathered electronically and was deidentified to maintain patient confidentiality. Comparison data was collected from
January 1, 2016 to March 31, 2016. The comparison sample included patients with CKD
stages four and five who were seen by the nephrology NP during this time period. The
intervention detailed above was implemented from January 1, 2017 to March 31, 2017.
Despite the great need identified in the literature review for this project, patients who
were eligible for the intervention were not willing to actively participate in an ACP
discussion. Demographic data were collected on patients with CKD stages four and five
who were seen in the clinic setting by the same nephrology NP who met project criteria
to receive the intervention. Demographic data is discussed below and detailed in pie
chart images. The greatest area demonstrating change with this intervention was clinical
significance and this will be discussed in detail below.
Demographics
Various demographic data were collected on both the comparison sample and
eligible intervention sample populations. These included age range of the patient, gender
of the patient, race of the patient, and stage of CKD. Age ranges were divided into 18-29
years, 30-49 years, 50-69 years, 70-89 years, and 90+ years. Possible gender choices
were male or female. Races sampled included African American, Caucasian, and Native
American. Finally, eligible stages of CKD were stages four and five based on GFR.
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Information on whether the patient had an existing AD document was also collected for
both the comparison sample and eligible intervention sample.
Comparison data. The comparison sample consisted of 10 patients. One patient
was between 30-49 years of age, four patients were between 50-69 years of age, three
patients were between 70-89 years of age, and one patient was older than 90 years of age.

Comparison Data: Age Range

18-29

30-49

50-69

70-89

90+

Figure 4. Age range of comparison sample of patients seen in the clinic setting by the
nephrology NP between January 1, 2016 to March 31, 2016.
Both males and females were equally represented in the comparison sample. Five
males and five females with CKD stages four and five were seen in the clinic setting by
the nephrology NP between January 1, 2016 to March 31, 2016.
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Comparison Data: Gender

Male

Female

Figure 5. Gender of comparison sample of patients seen in the clinic setting by the
nephrology NP between January 1, 2016 to March 31, 2016.
All of the comparison sample patients were of the Caucasian race.

Comparison Data: Race

African American

Caucasian

Native American

Figure 6. Race of comparison sample of patients seen in the clinic setting by the
nephrology NP between January 1, 2016 to March 31, 2016.
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The comparison sample included patients with CKD stages four and five. CKD
stage four was more common with seven patients. CKD stage five was less common
with three patients.

Comparison Data: Stage of CKD

Stage 4

Stage 5

Figure 7. Stage of CKD of comparison sample of patients seen in the clinic setting by the
nephrology NP between January 1, 2016 to March 31, 2016.
The comparison sample patients included both those with and without an existing
AD document. Five patients had an existing AD document and five did not.
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Comparison Data: Existing AD Document

No

Yes

Figure 8. Patients of comparison sample with an existing AD document who were seen in
the clinic setting by the nephrology NP between January 1, 2016 to March 31, 2016.
None of the patients who were part of the comparison sample had a documented
ACP discussion in their electronic medical record.
Intervention data. The intervention sample consisted of 14 patients who were
identified as having CKD stages four or five and by having a scheduled appointment with
the nephrology NP between the time period of January 1, 2017 to March 31, 2017. Two
patients were between 30-49 years of age, five patients were between 50-69 years of age,
and seven patients were between 70-89 years of age.
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Intervention Data: Age Range

18-29

30-49

50-69

70-89

90+

Figure 9. Age range of patients eligible for the intervention sample seen in the clinic
setting by the nephrology NP between January 1, 2017 to March 31, 2017.
The intervention sample consisted of seven males and seven females.

Intervention Data: Gender

Male

Female

Figure 10. Gender of patients eligible for the intervention sample seen in the clinic
setting by the nephrology NP between January 1, 2017 to March 31, 2017.
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A wide variety of races was represented in those eligible for the intervention
sample. A majority of the sample were Caucasian (11 patients), two patients were Native
American, and one patient was African American.

Intervention Data: Race

African American

Caucasian

Native American

Figure 11. Race of patients eligible for the intervention sample seen in the clinic setting
by the nephrology NP between January 1, 2017 to March 31, 2017.
CKD stages four and five were both represented in those eligible for the
intervention sample. Ten patients were identified as having CKD stage four. Four
patients had CKD stage five.
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Intervention Data: Stage of CKD

Stage 4

Stage 5

Figure 12. Stage of CKD of patients eligible for the intervention sample seen in the clinic
setting by the nephrology NP between January 1, 2017 to March 31, 2017.
Finally, of the patients with CKD stages four and five who were seen in the clinic
setting by the nephrology NP during the intervention period between January 1, 2017 to
March 31, 2017, seven had an existing AD document and seven did not. However, these
seven individuals without an existing AD document declined to participate in the
intervention for reasons discussed below.

ADVANCE CARE PLANNING

72

Intervention Data: Existing AD Document

No

Yes

Figure 13. Patients eligible for the intervention sample who were seen in the clinic
setting by the nephrology NP who had an existing AD document between January 1,
2017 to March 31, 2017.
Results
Clinical significance. The greatest impact of this project rests in its clinical
significance. The DNP Project coordinator conducted regular check-ins with the
nephrology NP and other members of the clinic staff throughout the course of the project.
Halfway into the intervention period, despite the inability to successfully recruit patients
to participate in the project, the nephrology NP identified her approach to her clinical
practice was changing. The nephrology NP had been taking time in her routine office
visits to verify that a patient had an existing AD document, even though this was already
completed by the nursing staff. Although half of the patients the nephrology NP saw
with CKD stages four and five during the intervention period had an existing AD
document, she was able to take a few minutes to discuss with the patients and individuals
present at the time of the appointment what the process of ACP was, why it was
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important, and also why it is considered to be a process that is never truly completed.
The nephrology NP encouraged all patients, both those with and without an AD
document, to think about addressing their end-of-life needs with those who are closest to
them. If a patient had developed an AD document a few years ago, the nephrology NP
also stressed the necessity of revisiting this document on a regular basis, ensuring what
he or she wanted at the end-of-life was still accurate and consistent with his or her health
and disease process. Although patient knowledge was unable to be directly assessed with
this intervention due to a lack of active patient participation, many patients were provided
with basic knowledge of the ACP process. This is only projected to increase as the
number of providers who are exposed to this process increases and as patients are offered
more ACP education.
The nephrology NP discussed this project with several of the other providers in
the practice throughout the three month intervention period. Most of the other providers
have realized the necessity of this intervention and do want to be able to integrate ACP
into the care of all of their patients but have not adopted this practice routinely. The
nephrology NP had provided education to other providers on ways to bring up these
sensitive topics with patients and key points patients with CKD need to consider in their
end-of-life care using the intervention tool developed for this DNP Project. This project
did not show statistical significance. However, the clinical significance and the
knowledge gained by the nephrology NP and other clinic providers demonstrated how
beneficial ACP is and how patients will routinely be exposed to and offered ACP at all of
their office visits with each of their providers.
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Statistical significance. Fourteen patients were identified as having CKD stages
four and five during the intervention period and were scheduled to be seen by the
nephrology NP during the implementation of this DNP Project. Half (seven) of these
patients had an existing AD document and per the institution request, were ineligible to
receive the developed intervention. The other seven patients declined to participate in the
intervention for a variety of reasons. Discussion with the nephrology NP highlighted a
few of these reasons, including not seeing the need to develop an AD document, having
never heard of ACP, and also not wishing to discuss this sensitive issue at the
appointment. The unpaired and paired t-tests and detailed statistical analysis were unable
to be completed with the lack of patient participation in the developed intervention. It
was also noted all patients that were identified to have CKD stages four and five who
were scheduled to see the nephrology NP had never participated in an ACP discussion.
This demonstrates the need to continue to introduce these patients to ACP and to educate
these patients about the necessity of a continuous ACP discussion with health care
providers and family members.
Summary
A lack of eligible and consenting patients was a major barrier to achieving
statistically significant results with this DNP Project. However, the clinical significance,
most notably the increased awareness of the nephrology NP and other clinic providers
and the initial education of the process of ACP with patients with CKD stages four and
five, was the greatest success of this project. Together, these two areas will help to
further transform the topic of ACP in research and practice and will provide health care
providers with a way to address ACP with their patients.
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Chapter 5
Conclusions
Discussion of Outcomes
This project aspired to achieve many outcomes, including increasing the number
of patients participating in an ACP discussion, increasing the number of patients
completing the intervention tool, and increasing knowledge of the ACP process. These
outcomes were unable to be directly assessed due to not having any participants in the
intervention sample. Statistical analysis could not be run with this project and these
results were not achieved.
The clinical significance of this project, however, indicates this intervention was
successful in other areas. The development of a standardized intervention that enabled all
providers to adopt this process into their practice and also an increase in overall provider
knowledge were two outcomes achieved with this project. The nephrology NP for this
project has now made it a routine practice in all of her clinic visits to ask patients whether
or not they have an AD document, even if this was already completed by the nursing
staff. The clinical practice of the nephrology NP has greatly changed since the beginning
of this project and this practice has continued despite the end of the project. Today, in
addition to asking each patient if they have an AD document, the nephrology NP is also
asking the patients when this document was last updated, if they have had any major
changes to their health since this time, and if they are satisfied with the choices they
made previously. Each patient is educated on the necessity of revisiting this document on
a regular basis and discussing what is listed in this document with those who are closest
to them to ensure their wishes at the end-of-life are carried out as they desire.
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Other providers in the same clinic setting are also beginning to use ACP with
many of their patients, regardless of the patients’ stage of CKD. The nephrology NP has
been a great resource for all of the other providers and has started to have discussions
with each of them as to how her own clinical practice is changing and how she is slowly
beginning to see a change in the attitude of her patients. Even though this project did not
show the great need to continue ACP in this patient population, the changing practice of
the providers shows how this practice can be incorporated into the care of all patients
with CKD. This intervention provides a written starting point for all providers in all
patient care settings. This process may be utilized more often and may produce
achievable and significant results as more patients are exposed to the process of ACP and
are asked about their AD document on a regular basis.
Limitations
The lack of patients included in this project sample was the biggest limitation for
this project and greatly hindered the ability to achieve statistically significant results. It
was identified by the DNP Project coordinator and the nephrology NP that there were no
participants in the intervention sample halfway through the intervention period. The
DNP Project coordinator contacted the Nursing Research Council of the health care
institution at which this project was implemented under the guidance of the DNP Project
advisor. This was done because prior to implementation of the DNP Project, the Nursing
Research Council requested that the intervention sample did not include patients who
already had an existing AD document. Information was provided to the Nursing
Research Council regarding the lack of eligible participants and the desire to include
patients with pre-existing AD documents. The Nursing Research Council approved the
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request to continue the intervention and to include those with existing AD documents for
the remainder of the intervention period. Together, the DNP Project coordinator, the
DNP Project advisor, and the nephrology NP decided to include those patients with CKD
stages four and five with an existing AD document in the last three weeks of the predetermined implementation period. Even despite these changes, patients did not agree to
participate in the intervention. The nephrology NP was very flexible in the
implementation of this project and enabled the clinical significance to be achieved. This
project could have easily become stagnant and changes could not have occurred during
the three month intervention period without the nephrology NP. The nephrology NP’s
willingness and desire to incorporate ACP into the routine care of patients with CKD
allowed clinical significance to occur.
The informal letter of invitation, informed consent form, pre- and postintervention knowledge assessment document, and discussion tool all had a very high
readability level. If these documents were to have been used, this would have been a
great limitation to this project. For some persons, it may have been difficult to read and
complete the documents and actively participate in the intervention for this reason. More
time would have been necessary to ensure the patients could understand what they were
being asked to decide upon. This limitation would have need to have been considered
when working with patients with a lower education level. Reading the documents and
questions to the patient by the nephrology NP or a family member would have been one
way to overcome this and still allow the patient to decide upon accurate goals for his or
her end-of-life care.
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Other than the initial meeting held prior to the beginning of the project, the DNP
Project coordinator had little interaction with the nursing staff. The individuals rooming
the patients were not trained in the use of ACP and in ways to approach this topic with
this patient population. This fact could have limited the number of willing participants.
This is an important factor to consider in future projects of this type.
This exact project is not continuing at this clinical practice site at this time but all
of the providers, especially the nephrology NP, are aware of the need for this practice and
are routinely investigating the AD status of each patient and also continuing to educate
each patient on the need to revisit and address these documents on a regular basis. The
process of ACP is not a one-time process but instead is continuous and must be revisited
on a regular basis, as was supported in the literature review. The TTM would help to
guide providers implementing this intervention to help them identify what stage of
change the patient is in. Patients in the precontemplation stage should be targeted with
education about the process of ACP and why it is important to one’s end-of-life care.
Once the patient has transitioned to the contemplation and preparation stages, the actual
process of ACP can then be implemented. This project confirms this evidence and with a
longer time frame for this project, more significant results could be achieved and patients
could agree to participate in the intervention.
Impact on:
Organization. The clinical significance achieved with this project was in line
with the vision and three core values of the health care institution where this project was
implemented. The clinical practice of the nephrology NP has been expanded to include a
review of the AD status of each patient seen in the clinic setting. The nephrology NP
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believes this process will continue in her personal practice. Both courage and passion are
qualities she has embodied since this project began. It is necessary to be willing to step
outside one’s comfort zone as a provider utilizing courage and passion to provide wellrounded care for patients with a chronic disease. The family value of this organization is
also met while talking with patients who already have an AD document and determining
if it is recent or if the patient would like to make changes to it.
Various organizational members were not enlisted to help disseminate these
results due to the lack of patient participation in this DNP Project. Once results are
obtained that show the statistical significance of this project, these persons will help
gather the support of other providers and patients in other settings. Education should
continue and providers should revisit developed ADs with their individual patient
populations as changes are made. The more routine the process becomes, the more
results that can be achieved.
Finances. The nephrology NP did spend a few more minutes with each patient
than she would have normally making sure each patient with CKD stages four and five
had an existing AD document and changes were not needed, even though intervention
tools and ADs were not completed during the implementation period of this project.
There were no direct cost increases with this initial project. However, as future projects
are completed and more patients and providers are enlisted to participate in ACP, more
time may be required to spend with the patients completing the intervention tool. The
financial impact should continue to be addressed with the use of any type of ACP
discussion. Providers should continue to be made aware of the ability to provide this
service to all Medicare patients and to use the diagnoses codes that are also available.

ADVANCE CARE PLANNING

80

Medicare and other insurance companies do see the necessity of ACP and it should be
translated to all health care areas and all patient populations.
If patients would have participated in the intervention and in the long run, a great
financial savings would have occurred for the health care institution. Nicholas et al.
(2011) showed those with ADs spent over $100,000 less on end-of-life care. This cost
savings could override any increased costs that may occur with the implementation of
this program, such as increased provider time spent with patients actively participating in
an ACP discussion. This would be an important factor to consider when choosing to
implement an ACP discussion in future settings and with other patient populations.
Policy decisions. The number of individuals participating in this project was less
than anticipated. Currently, changes in policies or procedures have not occurred in this
health care institution. The need for this change may be great as more providers are
made aware of the clinical significance of this project and the need for all individuals
with CKD to participate in ACP. Key organizational leaders will need to be enlisted to
help adopt and implement this change throughout the entire organization, including both
the inpatient and outpatient settings, once this project has shown to be successful with
increased participation and with statistical significance.
Quality of health care. It was hypothesized that patients with CKD would
benefit the most from an intervention of this type. However, this did not occur due to a
lack of patient participation. The nephrology NP had the greatest amount of change in
clinical practice and is now implementing an AD discussion with each of her clinic
patients. The provider is still talking with the patient and determining when the last
updates were made and what the patients’ desire is for his or her end-of-life care even if
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the patient has an existing AD document. This discussion, despite not using the
developed intervention tool, did help to establish a better connection between the patients
and family members who partook in this process. Its use will only continue to expand,
cost savings may result for the health care institution, and policy changes can be made as
more providers and patients are made aware of this process.
Direct patient and family member benefits were not able to be successfully
measured with this project. This should be the focus of future research and similar
projects. It is still anticipated patients will benefit from a higher quality of care
experienced at the end-of-life, a care that is congruent with their wishes at the end-of-life,
lower cost of care at the end-of-life, fewer hospitalizations and emergency department
visits, and an enhanced relationship with their health care provider. Family member
benefits may include less stress and anxiety about end-of-life decision making and
increased confidence caring for his or her family member who has developed an AD or
participated in ACP.
Rural or underserved populations. This project enabled patients from a variety
of settings the opportunity to participate in ACP. Regardless of what community the
patient lived in or how far he or she traveled to be seen in this outpatient clinic, each
patient meeting the inclusion criteria was offered the ability to complete the intervention
tool and formulate an advance care plan with the help of his or her family members,
caregivers, or the nephrology NP. Patients from a rural setting will experience an
enhanced awareness of services and options and can formulate an AD document stating
their exact wishes and desires for their end-of-life care as adjustments are made to this
project and as it continues to move forward.
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Again, as more patients participate and are allowed to formulate an advance care
plan, informed patients may choose to forgo more expensive, extensive, or invasive
procedures knowing many of these options may be unsuccessful long-term and may
result in unnecessary and higher medical costs. Education of eligible and consenting
patients remains a key component of the essential use of ACP. It is hoped that as ACP
continues to be utilized in all patients with chronic disease, those of rural and
underserved populations will experience an enhanced quality of life.
It was anticipated that non-English speaking patients would be included as part of
this project’s sample. However, non-English speaking patients were not seen during the
three month implementation period. Language barriers should not be a reason to forgo
implementing ACP in this population. It is still essential to provide these patients with
this service, even though more time will be needed to allow for translation and to ensure
adequate understanding of the process of ACP. ACP, even in non-English speaking
patients, will result in informed and educated patients who are able to access the health
care system successfully at the end-of-life.
New Evidence Generated for Practice
The literature review completed identified several gaps that were addressed with
this DNP Project. A lack of eligible and consenting patients with CKD stages four and
five did, however, greatly limit the amount of sustainable and effective results that could
be achieved with this project. The greatest barrier in developing this DNP Project was
the lack of an available intervention to use in patients with CKD. Therefore, a new,
effective intervention was developed for this project. It does cover some of the most
basic questions for a patient with CKD who is nearing the more advanced stages and
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provides a starting point for an ACP discussion. This document can be used by others
and provides health care providers a starting point for these difficult discussions.
More tangible evidence is needed outside of this project to support the use of ACP
in this patient population. ACP has shown to be successful in a wide range of patients
with other chronic diseases but further research still needs to focus on those with CKD.
Combined with this specific intervention and specific group of patients, a more
standardized process of communicating and discussing end-of-life issues, needs, and
treatment options can be addressed in a meaningful manner.
Recommendations for Future Projects
The major limitation to this project was the lack of eligible patients included in
the project sample. Future research should focus on expanding the number of patients
who are eligible to partake in an ACP discussion. This could be done in many ways,
such as including patients in lower stages of CKD, such as stages two or three, or having
more providers implement the process of ACP in their clinic settings. An NP in a
specialty practice setting, such as nephrology, often sees the less critical or seriously ill
patients. Including a physician in addition to a NP or other advance practice provider
may continue to expand the number of patients who would be eligible to receive this
intervention. If, with the help of these changes, patients who are seen in the clinic setting
with CKD are shown to benefit from the process of ACP, this intervention could then be
expanded to include patients in the hospital setting and patients with other chronic
diseases. The intervention used for this project has not shown to be unsuccessful and
should be continued.
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The length of time of project implementation should also be expanded in future
projects. Three months is a relatively short time frame to expect patients to make and
discuss their end-of-life decisions with their family members, caregivers, or health care
providers. A project involving ACP should last a minimum of six months but one year
would allow for true and successful results to be achieved. The process of ACP should
involve a continuous discussion between the patient and health care provider at each
office visit encountered in the health care system. The providers who have currently
been exposed to ACP should continue to use this practice in their daily patient
interactions, even in those who do not have a chronic health condition.
Other than the initial meeting before the project implementation, the nursing staff
rooming the patients received no education in regards to this specific project. The DNP
Project coordinator also never witnessed the rooming of a patient and this per chance was
a limitation to this project as actions and attitudes of the nursing staff in regards to ACP
were never directly assessed. As such, future projects should focus on education of the
all involved parties to ensure these extraneous variables or personal biases are accounted
for.
This project showed a great need to gather qualitative data in regards to why
patients were declining to participate in the process of ACP. The literature review
completed for this project showed a lack of patient knowledge of the process of ACP and
this was one of the most cited reasons for choosing not to participate in this specific
intervention. Patients also suggested they did not see the need to develop an AD
document or were not ready to make these decisions during their appointment. These
reasons did serve as barriers to the developed intervention. However, this qualitative data
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also serves to enhance future research in the area of ACP. This project shows education
about ACP must be implemented by providers prior to discussing end-of-life issues.
Once this process of education is completed, the patients will have a better understanding
of the necessity of ACP and will be more willing to participate in an intervention. Other
research projects focusing on ACP should also begin with education in order to achieve
the greatest outcomes. This type of data stresses the need to continuously engage patients
in an ACP discussion, as was also discussed in the literature review. An advance care
plan or AD is not something that can be developed in a short time frame and should
instead be discussed with patients during successive office visits and at each point of
contact in the health care system. The end result of improved education and enhanced
knowledge will greatly enhance patient care at the end-of-life.
ACP needs to be included early on in the care of a patient with a chronic disease,
despite the lack of patient participation and the lack of statistical results achieved with
this project. All health care providers will need to help prepare their patients for the endof-life and support them as they participate in this endeavor as the research continues to
grow with ACP and as patients continue to be exposed to ACP. It is the hope that ACP
will become a routine topic of discussion between health care providers, patients, and
family members or close friends.
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Appendix F: Literature Review Methods Table
Database(s) Searched Search Terms

Number of Results

Number Retained

Cochrane Library

2

1

24

10

59

6

16

1

0

0

467

2

568

20

CINAHL,
EBSCOhost

MEDLINE/PubMed

Ovid

USPSTF
AHRQ

Total

advance care
planning AND
CKD, advance care
planning AND
renal, advance care
planning AND
dialysis, Native
American AND
culture beliefs
advance care
planning AND
CKD, advance care
planning AND
dialysis, advance
care planning OR
advance directive
AND kidney failure
OR renal
insufficiency OR
dialysis patient OR
nephrology nursing,
Native American
AND culture beliefs
advance care
planning AND
CKD, advance care
planning AND
renal
advance care
planning OR
advance directive
AND kidney OR
renal OR chronic or
end-stage
advance care
planning
advance care
planning, chronic,
dialysis, renal
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Appendix G: Evidence Table

Citation

Level of
Evidence

Sample/Setting

Participants
(n)

Study Design/
Purpose

Intervention

Results

Agency for
Healthcare
Research
and
Quality.
(2014).

IVB

Sources were
extracted
through
database
searches
(PubMed,
Google,
Respecting
Choices
Website,
POLST
website) from
January 2012December
2013.

Not listed in
the CPG

CPG developed
to help achieve
improvements in
ACP through
development of
evidence-based
guidelines, to
assist
practitioners in
engaging
patients in ACP
discussions, to
recommend
interventions to
address ACP,
and to focus on
key components
of ACP

NA

Recommendations:
implement a
standardized ACP
process, assist
patients to use a
reliable and valid
ACP tool, help a
patient revise his or
her ACP at least
annually or with a
significant health
change, and
document the
patient’s goals in
their medical record.

Comments;
strengths and
limitations
CPG appraised
using the Agree
II tool – quality
rating of 4/7.
Updated version
of a previous
guideline. Not
specific to
patients with
CKD. Supports
use of ACP in a
variety of adult
patients.
Strengths:
Multiple key
recommendations
listed. Multiple
databases
searched.
Limitations:
Number of
extracted sources
or number of
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Agency for
Healthcare
Research
and
Quality.
(2015);
Renal
Physicians
Association &
American
Society of
Nephrology.
(1999).

IVB

1,062 articles
synthesized for
systematic
review
extracted
through
database
searches
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Not listed in
this CPG

CPG developed
NA
to provide
clinicians,
patients, and
family members
information in
regards to
benefits and
burdens of
dialysis, to
systematically
allow the health
care provider to
make individual
decisions for
special health
care
circumstances, to
synthesize

participants was
not listed. Not
listed if views of
public opinion
have been
sought. Few
resource
implications
discussed. No
update procedure
provided.
Recommendations:
CPG appraised
develop a patientusing the Agree
physician
II tool - quality
relationship for
rating of 5/7.
shared decision
Specific to
making, fully inform patients with
patients of their
CKD. Not
diagnosis, prognosis, specific to only
and all treatment
ACP
options, institute
interventions.
ACP, if appropriate, Supports use of
withhold dialysis in ACP in patients
individual patients,
with CKD.
and offer palliative
Updated version
care services to
of a previous
appropriate patients guideline –
(early on in the
reaffirmed 1999
disease process).
guideline from
the Renal
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available
research, to
provide a way to
make ethically
sound health
care decisions,
and to enhance
understanding of
processes used to
initiate or
withdraw
dialysis therapy

Amro, O.
VB
W.,
Ramasamy,
M., Strom,
J. A.,

Two outpatient
dialysis
facilities in
Boston, MA
from June

201 patients
with ESRD
receiving
outpatient
hemodialysis

Quality
improvement
project to help
develop an AD
method that is

Physicians
Association and
American
Society of
Nephrology.
Strengths: Indepth literature
search
completed. Indepth
methodology
listed.

Patients
identified by
a nephrologist
as having a
short life

An additional 12
patients opted for a
DNR order (p =
0.01). An increase
from 10% to 90%

Limitations:
Conflicts of
interest not
addressed. Few
costs
implications
addressed. Not
discussed
whether public
opinion was
sought.
Specific to
patients with
CKD. Shows
importance of a
face-to-face
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Weiner, D.
E., &
Jaber, B. L.
(2016).

Artsanthia,
J., Mawn,

2013 to July
2014

IIIB

Purposive
30 Thai
sample of older adults with

103
practical, widely
applicable, and
comprehensive

Mixed methods
focus group

expectancy
were invited
to participate
in a focus
group
encounter
dedicated to
ACP. Faceto-face
encounter was
held during a
routine
dialysis run
and lasted
from 15 to 60
minutes.

Focus groups
were held

was seen after the
intervention in
regards to
completion of an AD
form (p < 0.001).

Four major themes
developed:

encounter on
improving AD
rates.
Strengths: Large
sample size.
Statistically
significant
results. Study
conducted at a
time convenient
for all
participants.
Two different
dialysis settings
were used.
Limitations: No
control group
used for
comparison.
Sample size too
small to
determine impact
of culture or
religion on AD
completion or
DNR orders.
Specific to those
with CKD.
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B. E.,
Chaiphibalsarisdi, P.,
Nityasuddhi, D., &
Triamchaisri, S.
K. (2011).

adults living
with ESRD
and their
family
members.
Patients were
between the
ages of 50 and
80 years and
were followed
at a
hemodialysis
clinic in a
Bangkok
Hospital.
Family
members were
adults older
than 20 that
provided care
to a person
with ESRD,
were relatives
of a person
with ESRD, or
were identified
as community
leaders.

104
ESRD and 30 study focusing
family
primarily on
members
qualitative
methods to
explore the
needs of
palliative care
implemented
with individuals
with ESRD
living in
Bangkok,
Thailand

using a
qualitative
interview
guide to
explore the
physical,
emotional,
and spiritual
needs of
patients with
ESRD and
associated
family
members

tremendous
suffering, economic
consequences,
inadequate
community support,
and concern for the
future. These four
themes display the
wide range of issues
facing these patients.
Reveals the need for
an in-depth
palliative care
approach with these
patients that
addresses all of these
issues.

Shows the
importance of
integrating
palliative care
with patients
with ESRD.
Reinforced
cultural
importance of
palliative care
with CKD
patients.
Strengths: Small
focus groups but
adequate sample
size for study
design.
Limitations: Use
of purposive
sampling. Only
one
country/dialysis
center was used
in the study.
Need for further
research to
develop themes/
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Bristowe,
IIIB
K.,
Horsley, H.
L.,
Shepherd,
K., Brown,
H., Carey,
I.,
Matthews,
B., . . .
Murtagh,
F. E. M.
(2015).

Two large
London renal
centers that
service
approximately
1000
hemodialysis
patients at two
main and 10
geographically
dispersed
satellite units.
Participants
were sampled
by age (<65,
65 and over),
time spent on
dialysis (<12
months, 12-36
months, >36
months), and
symptom
burden and
from
November
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20
hemodialysis
patients, 11
participants
were female,
9 participants
were male

Qualitative
grounded theory
design that
aimed to explore
the experiences
of people living
with ESRD
regarding
starting dialysis,
its impact on
quality of life,
and their
preferences for
future care and
to explore the
ACP needs of
this population
and the timing of
this support

Semistructured
qualitative
interview that
occurred
during a
routine
dialysis
treatment.
Recruitment
occurred until
data
saturation was
reached.

Participants had a
variety of unmet and
unaddressed ACP
needs, including
fear, grief, denial,
shortage of
information
regarding illness and
prognosis, and a lack
of opportunity to
discuss concerns,
prognosis, and future
care.

quantitative data
more with this
population and
intervention.
Specific to
patients with
CKD. Supports
the need for
earlier ACP in
patients with
CKD/ESRD.
Strengths:
Convenient
location/time for
all participants.
Data saturation
was reached.
Limitations: Use
of purposive
sampling. Four
patients died
during the study.
Need for greater
research
(longitudinal
studies) to show
importance of
ACP and how
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2011 –
February 2012
Bullock, K. IIIA
(2011).

Focus groups
gathered from
Black and
white
communitydwelling
residents

202
participants
(black
participants n
= 102, white
participants n
= 100)

Qualitative focus
group grounded
theory design to
promote cultural
competency in
end-of-life care
that included
extended family
networks

Focus groups
responded to
guided
questions
about
preferences
for or against
end-of-life
care, control
and
autonomy,
attitudes and
beliefs about
death and
dying, and
questions in
regards to
ADs

Caucasians were
more likely than
African Americans
to have completed
an AD, wanted to
make their end-oflife care decisions
independent of
family members’
influence, and
viewed hospice care
more positively.
White older adults
tended to value
individualism,
independence, selfreliance, and future
orientation. African
Americans tended to
value collectivism,
interdependence,
interconnectedness,
and present
orientation.

outcomes change
with a specific
intervention.
Not specific to
those with CKD.
Discussed impact
culture has on
ACP and
differences
between African
Americans and
Caucasians.
Strengths:
Discussed
reliability of
cultural beliefs
scale.
Theoretical
saturation was
reached. Indepth statistical
analysis was
completed.
Limitations:
Setting of study
was never listed
making it hard to
generalize the
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Carrion, I.
V., NedjatHaiem, F.
R.,
MartinezTyson, D.,
&
Castañeda,
H. (2013).

IIIC

Purposive
sampling used
to recruit
Latina women
who selfidentified as
Colombian,
Mexican, or
Puerto Rican
and resided in
Central
Florida.
Participants
were recruited
from
community
health clinics,
churches,
cultural
centers, and
cancer support
groups.
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45 Latina
women

Qualitative
grounded theory
design to address
the lack of
literature
regarding ACP
and decision
making patterns
among
Colombian,
Mexican, and
Puerto Rican
women. This
study explored
cultural
perceptions and
identified factors
that facilitated
ACP completion
within this
specific
population.

60-90 minute
in-depth,
semistructured
interviews
composed of
broad and
open-ended
questions.
Interviews
were
conducted at
locations that
were
convenient
for the
women.

results or apply
to another
situation.
Four themes
Not specific to
developed: lack of
CKD. Discusses
knowledge of ACP, great cultural
a shared decision
barriers to using
making approach,
and
lack of information
implementing
and informal ACP,
ACP in a
and a key concern of culturally diverse
decision making.
population.
While there is a
Stresses need to
disconnect between
continue to
knowledge regarding educate this
the term ACP among group to improve
these women,
knowledge and
discussions
AD completion.
regarding this topic
still occurred. These Strengths: Data
women need the
analysis was
influence of family
completed in
in their decisions
both English and
and this highlights
Spanish.
the need for further
Research team
research involving
consisted of both
their family
English and
members. Higher
Spanish
levels of education
individuals.
point to a larger
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percentage of
completion of ADs
and ACP
conversations. The
number of years one
has been in the
United States also
influences their
ability to complete
an AD.

Collins,
M., &
Lehane, E.
(2013).

IIIB

Convenience
sample of adult
patients
receiving
hemodialysis
that attended a
dialysis unit at
an acute
hospital in
Ireland. Had
received

50
participants.

Nonexperimental
descriptive
cross-sectional
study design to
determine the
views of Irish
patients
receiving
hemodialysis on

Pre-defined
questionnaire
using closedended
questions
with a 5-point
Likert scale
response

Limitations: Use
of purposive
sampling.
Specific to
Colombian,
Mexican, and
Puerto Rican
women with
cancer which
greatly limits the
generalizability
of the results.
Data saturation
never discussed.
Validity and
reliability of
research methods
were not
discussed.
In regards to ACP,
Specific to CKD.
patients wanted
Stresses necessity
honest opinions
of ACP and
from their doctors.
giving patients
Patients wanted
honest opinions
some involvement in near the end-ofdecision making at
life. Family is
the end-of-life;
important to
however, they also
these patients as
wanted medical
they near the
interventions to keep end-of-life.
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hemodialysis
for a minimum
of three
months, had to
be able to read
and understand
English, and
were 18 years
of age and
older

Feely, M.
A. Swetz,
K. M.,
Zavaleta,
K.,
Thorstein-

IIA

Adult patients
18 years of age
and older who
received
hemodialysis
at a single
outpatient

death, dying, and
ACP

91 patients
participated
in specialist
palliative
medicine
consults

Quasiexperimental
study to
determine the
feasibility of
embedding
palliative

them around as long
as possible. Family
members play an
important role in the
patient’s lives, but
they are not
necessarily
comfortable
discussing end-oflife issues with
them.

Specialist
palliative
medicine
consultations
performed by
two boardcertified

Patients were wellreceiving of these
discussions and
preferred to
complete them
during dialysis.
After intervention,

Strengths:
Descriptive
statistics used to
summarize
results.
Limitations:
Results limited to
one dialysis unit.
Results limited to
patients from
Ireland. Further
statistical
analysis is
needed to
determine the
significance of
the results.
Reliability and
validity of study
questionnaire not
discussed.
Specific to those
with CKD.
Shows
importance of
palliative
medicine
consults.
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sdottir, B.,
Albright,
R. C., &
Williams,
A. W.
(2016).

Goff, S. L.,
Eneanya,
N. D.,
Feinberg,
R.,
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center between
January 1,
2012 and June
30, 2012

IIIB

Purposive
sampling from
dialysis units
in
Massachusetts

medicine
consultations
into the
outpatient
hemodialysis
setting and to
determine the
impact of this
intervention on
ACP and
symptom
management

13 patients
and 9 family
or friends
were
interviewed

Qualitative
grounded theory
design to
investigate how
dialysis teams

physicians
and occurred
during a
routine
hemodialysis
run. A chart
review was
completed
both before
and after the
intervention
to determine
documented
ADs, code
status, and
goals of care.

Interviews
conducted by
study team
members.
Interviews

54 patients had a
documented goals of
care discussion (p <
0.0001). Number of
patients electing a
full code status
increased after the
intervention (p <
0.0001).

Three emerging
themes: prior
experiences with
ACP, factors that
may affect

Effective if
implemented
during
hemodialysis
treatments.
Strengths: Large
sample size. Indepth statistical
analysis
completed.
Discussed
validity and
reliability of
measures used.
Limitations:
Purposive sample
used. Study took
place at only one
hemodialysis
center. No
control group.
Lack of
randomization.
Specific to CKD.
Involved both
patients and
family members.
Study identified a
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Germain,
M. J.,
Marr, L.,
Berzoff, J.,
. . . Unruh,
M. (2015).

and New
Mexico.
Participants
were invited to
bring up to two
family
members or
close friends to
also
participate.

111
during 15
sessions

should discuss
ACP

were
conducted
until
theoretical
saturation was
reached.

perspectives with
ACP, and
recommendations
for ACP. Themes
revealed that ACP
discussions rarely
occur yet most
patients and families
desire them, patients
desire a better
connection with
their nephrology
team, and that health
care providers
should lead ACP
discussions at least
annually.

need for an
interview guide
specific to
dialysis patients
or those with
CKD.
Strengths:
Interviews were
conducted until
theoretical
saturation was
reached. Validity
of interview
guide was
assessed prior to
implementation.
Limitations:
Although
theoretical
saturation was
reached, the
small sample size
might have
prevented
additional themes
from being
exposed.
Interviews were
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Harrison,
K., &
Watson, S.
(2011).

IIB

Recruited from
a nephrology
clinic. Patients
had previously
chosen
conservative
management
for CKD or
were in need of
decisionmaking
support. Clinic
took place in a
renal satellite
hospice unit
during October
2008 – October
2009.
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18 patients
were seen for
a total of 50
consultations
over the time
period of one
year

Quasi
experimental
design to
investigate the
effects of a
nurse-led
palliative care
clinic on patients
with CKD stage
five and their
carers

Nurse-led
monthly
educational
palliative care
clinic (led by
a hospice
nurse and a
renal
palliative care
nurse) aimed
to provide
optimal
symptom
management,
empower
patients to
make their
own choices,
and to support
them in ACP

Patients found the
clinic to be helpful
to help appropriately
manage the
underlying condition
and symptoms with
a continuity of care.
Patients were
exposed to palliative
care earlier on in the
disease process than
commonly occurs.
Patients felt
supported, had an
opportunity to make
ACP decisions with
family present.
Family caregivers
reported a better
understanding of the
disease, felt more
prepared for the
future, and less
anxious.

conducted in
only two states,
which may limit
the
generalizability
of these results.
Specific to CKD.
Generally the
clinic was wellevaluated.
Involved patients
both before
dialysis initiation
and while
receiving dialysis
therapy.
Involved patients
and family
members.
Strengths: 75%
of surveys were
completed after
the intervention.
Limitations:
Small sample
size. Six patients
died during the
course of the
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KataokaIIIB
Yahiro, M.
R.,
Yancura,
L. A.,
Page, V., &
Inouye, J.
(2011).

Purposive
sample of
Asian-Pacific
Islanders
recruited from
a dialysis
center located
in Oahu, HI.
Had to be
family
caregivers for
patients
receiving
hemodialysis
for CKD stage
four and stage
five. Data was
collected
between May
2009 and
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14 AsianPacific
Islander
family
caregivers of
persons
receiving
hemodialysis

Qualitative
grounded theory
study design to
describe the
attitudes,
subjective
norms, and
perceived
behavioral
control among
Asian-Pacific
Islander family
caregivers of
those receiving
hemodialysis for
CKD stage four
and stage five

Four focus
group
sessions held
at the dialysis
center that
lasted one
hour to 90
minutes.

Completion of ACP
and ADs are
associated with
peace of mind and
ease of making
future decisions. It
also prevents
burden, minimizes
family disputes, and
allows family
members to see
problems ahead of
time. Most family
members desired to
feel comfortable
with ACP and ADs
so that they were
able to carry out
patient wishes and
not be a burden to
his or her family.

study. Statistical
analysis of study
results not shown
or discussed.
Validity and
reliability of
intervention and
post-survey not
discussed.
Specific to CKD.
Discussed
benefits of ACP
on family
members. Shows
necessity of
involving family
members in ACP
and end-of-life
care, especially
in the AsianPacific Islander
population.
Strengths: Data
was collected
until theoretical
saturation was
reached. Two
authors read and
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September
2009.

Kirchhoff,
K. T.,
Hammes,
B. J., Kehl,
K. A.,
Briggs, L.
A., &

IIC

Two health
centers in
Wisconsin
with associated
clinics and
dialysis units

Family is first and
primary in decision
making.

153
participants
in the control
group (64
with ESRD,
90 with
CHF). 160
participants

Quasi
experimental
post-test only
design to
compare patient
preferences for
end-of-life care
with care

Patient
centered ACP
interview
with patient
and family
members
lasting
between one

In CPR, 43.5% of
the intervention
patients had
outcomes matching
their initial
preferences.
However, almost
one-third of patients

analyzed focus
group transcripts.
Limitations:
Purposive sample
used from one
dialysis center.
Sample taken
from one state.
Need for more
quantitative
research in this
area to determine
true cultural
barriers and
resource
implications.
Validity and
reliability of
focus group
questions not
discussed.
Study not
specific to
patients with
CKD. Involved
patients and
family members.
Results indicate
that intervention
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Brown, R.
L. (2012).
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in the
intervention
group (70
with ESRD,
90 with
CHF).
Patients and
family
members
were
recruited as
pairs.

received at the
end-of-life

and one and a
half hours.

changed their mind
about CPR
preferences. For
patients with ESRD,
more intervention
patients than control
(37.7% versus 17%)
chose to withdraw
from dialysis.

patients may
choose fewer
life-sustaining
interventions
near the end-oflife, but the
differences were
not shown to be
statistically
significant.
Strengths: Study
looked at patients
with two
common chronic
illnesses. Posttest only study
design used to
determine effect
of intervention.
Limitations:
Potential effects
of the study
could have been
reduced due to
patient death
(110 patients
died before the
end of the study).
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Luckett, T., IB
Sellars, M.,
Tieman, J.,
Pollock, C.
A.,
Silvester,
W., Butow,
P. N., . . .
Clayton, J.
M. (2014).

55 articles
Not listed in
reporting on 51 the metadiscrete
synthesis
samples
included (7
intervention
records, 48
other records).
Sample
included adults
with CKD
and/or families
caring for this
group of
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Meta-synthesis
using both
quantitative and
qualitative
designs to
identify what
interventions
have been
developed,
piloted, and
evaluated in
regards to ACP
in patients with
CKD, to identify

Studies used a
variety of
methods –
teaching
sessions,
videos,
telephone
interviews,
printed
materials, and
face-to-face
education
with
physicians.

Two studies found
ACP to have a
significant effect on
both patientclinician
communication and
interaction. One
study increased AD
completion rates. In
one study, 76% of
nephrologists were
in favor of an ACP
intervention while
70% of patients

Study was
completed only
in one state and
involved only
those with ESRD
and CHF (great
limit on
generalizability).
Statistical
analysis of study
results not shown
or discussed.
Validity and
reliability of
intervention not
discussed.
Specific to CKD.
Both qualitative
and quantitative
studies were
included in this
review. This
study was the
first metasynthesis to focus
on ACP in those
with CKD.
Findings were
not found to be
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patients (44
articles
involved
patients with
CKD and 6
articles
involved
families/caregivers). All
patient samples
included
people with
CKD stage 5
and 2 articles
included
patients with
CKD stage 4.
5 articles took
place in the
inpatient
setting while
24 articles
involved the
outpatient
setting. 35
articles took
place in the
United States.
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what measures
have been used
in intervention
and other
research studies,
to establish
evidence for the
efficacy of
interventions,
and to inform
understanding of
barriers and
facilitators to
implementation
of ACP.

found an AD
pamphlet helpful.
No studies found a
significant effect for
patient/surrogate
decisional conflict.
However, two
studies found a
significant effect for
congruence between
patient wishes and
surrogate knowledge
of those wishes after
an ACP intervention.

significant across
multiple studies.
Strengths:
Comprehensive
approach to ACP
that focused on
patient,
caregiver, and
system related
factors. Most
research in
regards to ACP
and CKD has
been descriptive
in nature and this
meta-synthesis
followed this.
Limitations: Key
search terms
were not listed in
the study
description. Data
extraction was
completed by
only one
researcher. No
studies included
measured
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Nicholas,
L. H.,
Langa, K.
M.,
Iwashyna,
T. J., &
Weird, D.
R. (2011).

IIIA

Health and
Retirements
Study
respondents
who died
between 1998
and 2007 at
age 65 years or
older after
qualifying
through
Medicare
through
disability or
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3302
decedents

Nonexperimental
descriptive
cohort study to
examine the
relationship of
ADs with the
cost and
aggressiveness
of end-of-life
treatment in the
United States

Post-mortem
interview
conducted
with next-ofkin. Asked
about the
decedent’s
experience at
the end-oflife, including
the nature and
type of their
AD. Chart
review

Those with
treatment-limiting
ADs had lower rates
of life-sustaining
treatments (p =
0.02), lower rates of
in-hospital death (p
< 0.01), and higher
rates of hospice use
(p < 0.01). Those
with ADs were more
likely to be white,
affluent, and highly
educated. Decedents

compliance with
patient wishes for
end-of-life care.
Only one
intervention
study
demonstrated the
effect on patient
and family
outcomes. None
of the
intervention
studies looked at
the effect of ACP
on bereaved
family members.
Not specific to
CKD but does
discuss those
with ESRD.
Strengths: Large
sample size.
Studied Medicare
decedents
throughout the
United States.
Large amount of
statistical
analysis.
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ESRD. Had to
be enrolled in
fee-for-service
Medicare
during the last
six months of
life

Oczkowski
, S. J.,
Chung, H.,
Hanvey,
L.,
Mbuagbaw
, M., &
You, J. J.
(2016).

IA

67 articles
Not listed in
obtained from this metastudies
synthesis
conducted in
the ambulatory
setting
(included 47
qualitative
only studies for
future review,
19 ICU-based
studies, 18
inpatient, nonICU studies,
and 20
educational
studies)

calculated
Medicare
spending in
the last six
months of life
across all care
settings

Meta-synthesis
using both
qualitative and
quantitative
study designs to
determine the
effect of
structured
communication
tools for end-oflife decision
making on
completion of
ADs in the
ambulatory care
setting

Variety of
interventions
examined:
verbal
discussion
alone, paper
tools alone,
verbal
discussion
combined
with paper
tool, and
computer
programs

residing in lowspending regions
were more likely to
have treatment
limiting ADs (p <
0.01). End-of-life
spending was lower
for decedents in lowspending regions
than those in higher
spending regions.
Interventions were
associated with a
statistically
significant increase
in frequency of ACP
discussions (p =
0.007) and
frequency of
completion of ADs
(p < 0.001). For
patients who died
throughout the
course of the studies,
the communication
tools were
associated with a
statistically
significant increase
in the congruence of

Limitations:
Nonexperimental
design limits
ability to
determine casual
effect.

Not specific to
patients with
CKD. Showed
great benefits of
using structured
communication
tools to improve
frequency of
ACP and
acceptability of
these discussions
with patients and
family members.
Looked at the
effect of ACP
with family
members.
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care desired by
patients (p = 0.004).
Communication
tools reduced
patient’s desire for
life-sustaining
treatments but was
not statistically
significant (p =
0.02). Knowledge
of family members
was enhanced with
the use of structured
communication tools
(p < 0.001). All
studies found
communication tools
to be equally or
more acceptable
than usual care.

Strengths:
Involved both
qualitative and
quantitative
studies targeted
to ACP. Showed
importance of
ACP for patients
with cancer, lung
disease, heart
disease,
neurologic
disease, and renal
disease. In-depth
description of
study
methodology and
data extraction
methods. Two
separate authors
were used to
screen studies.
Discussed a wide
variety of
interventions to
use as
communication
tools.
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Song, M.,
Ward, S.
E., Fine, J.
P., Hanson,
L. C., Lin,
F., Hladik,
G. A., . . .
Bridgman,
J. C.
(2015).

IB

Recruited from
20 outpatient
dialysis centers
in 8 counties in
North Carolina
between March
2010December
2012
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420
participants
from 20
dialysis
centers.
Patient and
family
members
were
recruited as
pairs
(intervention
group n =
109, control
group n =
101)

RCT that
examined the
efficacy of an
ACP
intervention on
preparation for
end-of-life
decision making
for dialysis
patients and
surrogates and
for surrogate’s
bereavement
outcomes

Intervention
group took
part in a
psychoeducational
intervention
(Sharing
Patient’s
Illness
Representations to
Increase Trust
[SPIRIT]).
SPIRIT
consists of
two sessions.
All sessions

Congruence in goals
of care for both
patients and
surrogates was
higher in those who
participated in the
SPIRIT intervention
at two and six
months, but the
effect was not
significant across all
time points. Patient
decisional conflict
decreased over time
in those who
participated in
SPIRIT (p = 0.01).

Limitations:
Studies limited to
those in
ambulatory
settings. Even
despite
statistically
significant
findings, many
studies were
found to be of
low-quality when
appraised.
Specific to CKD.
Involved both
patients and
family members.
Results show that
patient and
surrogate
congruence may
not be sustained
over time, which
shows the need
for ongoing
intervention with
this group.
Strengths: This
is the first trial to
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included both
patient and
family
members.

Surrogate decision
making confidence
scale scores were
high at all time
points. The SPIRIT
intervention effects
on congruence and
surrogate decision
making confidence
score were
statistically
significant at p =
0.03 and p = 0.03
respectively.
However, the effect
of dyad congruence
was significantly
decreased at 12
months (p = 0.04)
for those in the
intervention group.
Depression scores in
those who were part
of the SPIRIT
intervention were
significantly lower
at 3 months and 6
months (p = 0.01).

show effects of
bereavement
outcomes of
surrogates of
patients with
ESRD. This is
the only RCT to
demonstrate
positive effects in
a sample with
African
Americans.
Limitations: 45
persons died
during the study.
Study was
conducted in a
single United
States region.
Data collection
methods were not
clearly described
in the article.
Validity or
reliability of the
instruments used
was not fully
discussed.
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Waite, K.
R.,
Federman,
A. D.,
McCarthy,
D. M.,
Sudore, R.,
Curtis, L.
M., Baker,
D. W., . . .
PaascheOrlow, M.
K. (2013).

IIIA

Adults aged 55
to 74 were
recruited from
an internal
medicine clinic
or one of four
federal health
centers in
Chicago
between
August 2008
and November
2010.

123
784 adults
were
included in
analysis
(two-thirds of
the
participants
were female)

Nonexperimental
descriptive
correlational
study design to
examine the
effect of the
relationship
between literacy
and other
individual-level
factors on having
an AD

Face-to-face
structured
interviews
with a trained
interviewer,
completed for
4 hours
divided over
2 days

Literacy skills were
strongly associated
with having an AD –
12.4% with low
literacy, 26.6% with
marginal literacy,
and 49.5% with
adequate literacy (p
<0.001). Race was
also associated with
having an AD –
African Americans
22.9%, white 57.2%
(p < 0.001). Other
factors associated
with AD completion
include older age,
higher education,
higher income, parttime employment,
and fewer chronic
health conditions.

Study not
specific to
patients with
CKD. Strong
statistically
significant
correlation
between health
literacy and
having an AD.
Suggests need to
target the
population of
patients with a
lower health
literacy.
Strengths: Indepth statistical
analysis
completed.
Large sample
size. Looked at
multiple
variables other
than just health
literacy.
Limitations: No
reliability or
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Walton, J.
(2011).

IIIB

Nonrandomized
convenience
sample of
college
students.
Participants
were primarily
Caucasian;
ages ranged
from 18 to 45
with a majority
of the
participants
ages 22 years
and female

124

95 college
students (65
were enrolled
in a health
science
course from a
liberal arts
college in the
rural
Northwest;
30 student
nurses
attending a
Montana
nursing
association
conference)

Mixed methods
design involving
quantitative and
qualitative study
designs.
Quantitative
component
involved a preand post-survey
to assess if there
was a
statistically
significant
difference in the
knowledge and
cultural
awareness of
students
following an
educational
intervention by a

60 minute
educational
presentation
based on
research
findings from
a study
entitled
Prayer
Warriors: A
Grounded
Theory Study
of American
Indians
Receiving
Hemodialysis

validity of
interview
questions
discussed.
Participants in
this study were
mainly African
American and
Caucasian.
Students can learn
Specific to
cultural awareness to Native
Native Americans
Americans with
receiving dialysis
CKD. Shows
and apply cultural
importance of
interventions
cultural
following an
awareness when
educational session. working with the
Five themes
Native American
emerged from the
culture. Shows a
case study findings: brief educational
approaching the
period can
patient with an open enhance the
mind, assessing
relationship
beliefs and culture,
between a patient
educating and reof another culture
educating with the
and a health care
patient and family,
provider.
convincing the
patient to begin
Strengths:
Sufficient sample
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nephrology
nurse.
Qualitative
component
involved
students writing
a reflection
paper of a case
study of a young
Native American
patient with
CKD.

dialysis, and creating size for the study
a sacred space.
design. Involved
two methods of
assessing cultural
barriers to
providing care to
the Native
American
population.
Intervention was
based off of a
prior research
study.
Limitations:
Sample
population was a
non-randomized
convenience
sample of
students from
two different
settings. Sample
was primarily
female and
around the same
age. Pre- and
post-survey was
developed from
the findings of
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White, B.,
Tilse, C.,
Wilson, J.,
Rosenman,
L., Strub,
T., Feeney,
R. &
Silvester,
W. (2014).

IIIB

National
sample of the
Australian
adult
population
(aged 18 and
above)
conducted
between
August and
September
2012
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2405
individuals
agreed to be
interviewed
with 50%
being female

Nonexperimental
cross-sectional
descriptive
prevalence study
to determine the
prevalence of
ADs in the
Australian
population

National
telephone
survey

Only 14% of
respondents had
prepared an AD.
Respondents with a
financial EPA were
almost nine times
more likely to have
an AD than those
without.
Respondents with a
living will were 2.5
times more likely
than those without to
have an AD.
Respondents who
were either single or
not in a legally
recognized
relationship were 1.7
times more likely
than those who were
married to have an
AD.

another research
article.
Reliability and
validity of this
instrument was
never discussed.
Results not
specific to those
with CKD.
Strengths: Equal
representation of
males and
females. Diverse
age of sample.
In-depth
statistical
analysis was
completed.
Limitations:
Study was
completed in
only one country.
Low response
rate to telephone
survey. Small
sample size in
comparison to
entire population.
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Only discussed
ADs and not
other legal
documents.
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Appendix J: Pre-Intervention Knowledge Assessment

Advance Care Planning for Patients
with Chronic Kidney Disease
Answer the following questions below before your discussion with
the health care provider.
1. An advance directive is a document that:
o Expresses an individual’s medical wishes when that person is unable to speak
for him- or herself
o Determines who will handle one’s financial affairs after death
o Explains one’s rights as a patient
o I don’t know
2. Advance directives go into effect if an individual:
o Gets admitted to the hospital
o Has a terminal medical condition
o Can no longer communicate his or her health care decisions
o I don’t know
3. In general, the best person to serve as an individual’s health care surrogate is the person
who:
o Has the most knowledge
o Is best able to represent the individual’s views
o Has known the individual the longest
o I don’t know
4. Of the following, which is least important for a patient to do regarding advance care
planning?
o Discuss their values and wishes regarding end-of-life care with trusted family
members and friends
o Create an advance directive that explains their goals of care
o Provide their physician(s) with the advance directive
o Use a state-specific living will form
5. Advance care planning is a one-time process and does not need to be revisited during the
course of a patient’s life.
o True
o False
6. If an individual has decision-making capacity and can still speak for him- or herself, an
advance directive does NOT determine which medical treatments they will receive.
o True
o False
(Adapted from Green & Levi, 2011)

ADVANCE CARE PLANNING

131

Appendix K: Post-Intervention Knowledge Assessment

Advance Care Planning for Patients
with Chronic Kidney Disease
Answer the following questions below after your discussion with the
health care provider.
1. An advance directive is a document that:
o Expresses an individual’s medical wishes when that person is unable to speak
for him- or herself
o Determines who will handle one’s financial affairs after death
o Explains one’s rights as a patient
o I don’t know
2. Advance directives go into effect if an individual:
o Gets admitted to the hospital
o Has a terminal medical condition
o Can no longer communicate his or her health care decisions
o I don’t know
3. In general, the best person to serve as an individual’s health care surrogate is the person
who:
o Has the most knowledge
o Is best able to represent the individual’s views
o Has known the individual the longest
o I don’t know
4. Of the following, which is least important for a patient to do regarding advance care
planning?
o Discuss their values and wishes regarding end-of-life care with trusted family
members and friends
o Create an advance directive that explains their goals of care
o Provide their physician(s) with the advance directive
o Use a state-specific living will form
5. Advance care planning is a one-time process and does not need to be revisited during the
course of a patient’s life.
o True
o False
6. If an individual has decision-making capacity and can still speak for him- or herself, an
advance directive does NOT determine which medical treatments they will receive.
o True
o False
(Adapted from Green & Levi, 2011)
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Appendix L: Intervention Tool

Advance Care Planning for Patients
with Chronic Kidney Disease
Advance care planning is a communication process that takes place
between the patient, family member or close friend, and/or the health
care provider. The patient’s preferences for future medical care is
decided. Read and discuss the questions below with a family
member, close friend, or health care provider. Write your wishes on
the lines below. Keep a copy for your records and return the
completed form to a clinic staff member.
o If you become unable to make decisions for yourself, whom do you want to make
decisions for you?
_____________________________________________________________________
_____________________________________________________________________
o If you had to choose between being kept alive as long as possible regardless of
personal suffering or living a shorter time to avoid suffering and medical procedures
such as breathing machines and feeding tubes, which would you pick?
_____________________________________________________________________
_____________________________________________________________________
o Under what circumstances, if any, would you want to stop dialysis?
_____________________________________________________________________
_____________________________________________________________________
o Under what circumstances, if any, would you not want to be kept alive with medical
means such as cardiopulmonary resuscitation, a feeding tube, or mechanical
ventilation?
_____________________________________________________________________
_____________________________________________________________________
o Where do you prefer to die and whom do you wish to be with you when you die?
_____________________________________________________________________
_____________________________________________________________________
(Renal Physicians Association & American Society of Nephrology, 1999; AHRQ, 2015)

Patient Signature: __________________________________ Date: _____________
Notary Signature: __________________________________ Date: _____________
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Appendix M: Informal Letter of Invitation
Dear patient:
I, Chelsea Hinders, am conducting a project entitled "Implementation of an Advance
Care Planning Discussion for Patients with Chronic Kidney Disease" as part of a Doctor of
Nursing Practice project at South Dakota State University. The purpose of the project is to
implement a standardized process of advance care planning specific to patients with chronic
kidney disease stages four and five in an urban outpatient setting.
You as a patient are invited to participate in the project by actively participating in a
discussion during your office visit with a nephrology Nurse Practitioner and completing a
test before and after the discussion. We realize that your time is valuable and have attempted
to keep the requested information as brief and concise as possible. It will take you
approximately 30 to 40 minutes of your time. Your participation in this project is voluntary.
You may withdraw from the project at any time without consequence.
There is minimal risk to you for participating in this study. An advance care planning
discussion collects information about sensitive goals of care issues and asks questions that
could possibly cause psychological distress, discomfort, and anxiety beyond what is
experienced in daily conversation. As a participant, you will have the option of not
answering any questions which you find upsetting.
The benefits to you include having a document that states your exact wishes for your
goals of care in your medical record. Your health care provider and family members or
caregivers will also be made known of your wishes and will be able to carry out your desires
should the time arise. Your responses are strictly confidential. When the data and analysis
are presented, you will not be linked to the data by your name, title or any other identifying
item. Please assist us in our project and participate in the discussion with the nephrology
Nurse Practitioner and complete a test before and after the discussion.
Sincerely,
Chelsea Hinders
nephrologyacp@gmail.com
605-610-9039
o I agree to participate

o I decline to participate
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Appendix N: Informed Consent Form

Sanford Health
Consent to Participate in a Study
Title: Implementation of an Advance Care Planning Discussion for Patients with Chronic
Kidney Disease
Principal Investigator: Chelsea Hinders
What is the purpose of this study?
The purpose of this study is to implement a standardized process of advance care planning
specific to patients with chronic kidney disease stages four and five in an urban outpatient
setting.
What will happen during this study?
As a participant in the study, you will be participate in a discussion regarding end-of-life
wishes and care with a Nurse Practitioner. Your family members and/or those who are with
you today will also be asked to participate in the conversation. Five specific questions will
be used to guide the conversation. Your answers will be written down and placed into your
electronical medical record to reference at future appointments and during future
hospitalizations. Your answers can be changed at any time and the questions can be
answered at a future date. This study will serve as a facilitator of end-of-life discussions and
will help guide your future health care.
Your participation in the study will last during this office visit only. No return appointments
specific to this study will be required. Participation in the study will take approximately 30
to 40 minutes of your time.
What are the risks of the study?
There may be some risk from being in this study but any risk for participating is not expected
to be more than risk experienced in everyday life. An advance care planning discussion
collects information about sensitive goals of care issues and asks questions that could
possibly cause psychological distress, discomfort, and anxiety beyond what is experienced in
daily conversation. As a participant, you will have the option of not answering any questions
which you find upsetting.
What are the benefits of this study?
You may not benefit personally from being in this study. However, we hope that, in the
future, other people might benefit from this study by having exact end-of-life wishes
documented clearly in an electronic medical record. Care at the end-of-life will be enhanced
and individual patient wishes will be upheld during this difficult time.
What are the alternatives to participating in this study?
The alternative is to not participate in this study.
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Are my records confidential?
While we cannot guarantee absolute confidentiality, we will use all available security
measures to minimize the risk that this information would be given to someone outside of the
study. Your study record may be reviewed by the Sanford Institutional Review Board (IRB)
and Sanford Research Compliance.
If we write a report or article about this study, we will describe the study results in a
summarized manner so that you cannot be identified. Confidentiality will be maintained by
means of de-identifying personal data. Any personal information collected will be stored in a
locked filing cabinet in the clinic only accessible by the project coordinator, the nursing staff,
and the Nurse Practitioner.
An Electronic Medical Record (EMR) is an electronic version of the record of your care
within a health system. An EMR is simply a computerized version of a paper medical
record. If you are receiving care or have received care at Sanford (outpatient or inpatient)
and are participating in a Sanford study, results of related procedures (i.e. laboratory tests,
imaging studies and clinical procedures) may be placed in your existing EMR maintained by
Sanford. The completed advance care plans will be placed into your EMR to be accessible
by health care providers and staff during future office visits and hospitalizations.
Is this study voluntary?
Your participation is voluntary. You can choose not to participate or you may stop your
participation at any time without penalty or loss of benefits to which you are otherwise
entitled.
Your decision whether or not to participate will not affect your current or future relations
with Sanford Health.
Who can I talk to?
You may ask any questions you have now or later.
If you have questions, concerns, or complaints, or think the study has hurt you, talk to the
team at (605) 610-9039 or nephrologyacp@gmail.com
For this study you must be 18 years of age older to consent to participate in this study.
Your signature documents your permission to take part in this study.

Signature of subject
Printed name of subject

Date
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Date
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Appendix O: Project Procedure Algorithm

Advance Care Planning Procedure
Algorithm
RN/LPN to print NP schedule each AM

RN/LPN and NP determine which patients are eligible to receive the intervention (CKD
stages four and five, GFR less than 30 mL/min/1.73 m2). Place an asterisk on the printed
schedule next to each who is eligible to receive the intervention. Place printed schedule by
the clinic receptionist.

Clinic receptionist to give each eligible patient an informal letter of invitation at the time of
registration

While rooming the patient, RN/LPN collect informal letter of invitation from all patients with
marked response (I agree to participate or I decline to participate). If patient agrees to
participate, RN will then ask patient if he or she has an advance directive document. If
patient does not, then give and collect informed consent form from patient. Administer preassessment knowledge test to patient after completing rooming activities. Keep all forms in
collected in locked filing cabinet.
(Continue through care as usual if patient already has an advance directive.)

RN/LPN report off to NP whether patient has an advance directive document. NP to
implement intervention using the five question tool if patient does not have an advance
directive. NP collect form from patient if completed during the clinic visit and give to
RN/LPN. Clinic manager to notarize document. Copy completed document. Scan to
medical records. Send copy to medical records. Keep original in locked filing cabinet. RN
to administer post-assessment knowledge test to patient after the discussion. Keep
assessment documents in locked filing cabinet. NP to document in clinic note regarding
discussion.
**(If intervention tool is returned at a later date, follow same instructions above for scanning
to medical records.)**

